{"span_id": "4f23792c51362ea7", "trace_id": "7f02306a843106dc306821f1e498f6bd", "parent_id": null, "name": "tool.categorization.gamp_analysis", "kind": "INTERNAL", "start_time": 1755774985203670500, "end_time": 1755774985204547700, "duration_ns": 877200, "status": {"status_code": "OK", "description": null}, "attributes": {"tool.name": "gamp_analysis", "tool.category": "categorization", "tool.type": "pharmaceutical_agent_tool", "tool.function": "gamp_analysis_tool", "compliance.gamp5.category": "tool_execution", "compliance.audit.required": true, "compliance.pharmaceutical.tool": true, "tool.critical": true, "tool.regulatory_impact": true, "tool.input.arg_count": 1, "tool.input.kwarg_count": 0, "tool.input.arg_types": "['str']", "tool.execution.duration_ms": 0.7448196411132812, "tool.execution.status": "success", "tool.output.type": "dict", "tool.output.dict_keys": "('predicted_category', 'evidence', 'all_categories_analysis', 'decision_rationale', 'summary')"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:25.204651", "span_type": "tool", "tool_name": "gamp_analysis", "tool_category": "categorization"}
{"span_id": "1cbafe8b14c9db33", "trace_id": "8ad553995b9c7d825b09b5ff91c48a27", "parent_id": null, "name": "tool.categorization.confidence_scoring", "kind": "INTERNAL", "start_time": 1755774985205671200, "end_time": 1755774985205772600, "duration_ns": 101400, "status": {"status_code": "OK", "description": null}, "attributes": {"tool.name": "confidence_scoring", "tool.category": "categorization", "tool.type": "pharmaceutical_agent_tool", "tool.function": "confidence_tool", "compliance.gamp5.category": "tool_execution", "compliance.audit.required": true, "compliance.pharmaceutical.tool": true, "tool.critical": true, "tool.compliance_required": true, "tool.input.arg_count": 1, "tool.input.kwarg_count": 0, "tool.input.arg_types": "['dict']", "tool.execution.duration_ms": 0.0209808349609375, "tool.execution.status": "success", "tool.output.type": "float"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:25.205828", "span_type": "tool", "tool_name": "confidence_scoring", "tool_category": "categorization"}
{"span_id": "e34a128ef72f8f93", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "68bc21befb1a66a8", "name": "chromadb.query", "kind": "INTERNAL", "start_time": 1755774987584268300, "end_time": 1755774987627322200, "duration_ns": 43053900, "status": {"status_code": "UNSET", "description": null}, "attributes": {"vector_db.operation": "query", "compliance.gamp5.vector_operation": true, "compliance.pharmaceutical": true, "data_integrity.vector_search": true, "chromadb.query.n_results": 10, "chromadb.query.status": "success", "chromadb.query.result_count": 10, "chromadb.query.avg_distance": 0.8034217417240143}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.627439", "span_type": "vector_database", "database_type": "chromadb", "operation": "query", "result_count": 10, "avg_distance": 0.8034217417240143}
{"span_id": "8bf0955b01f2ef65", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "68bc21befb1a66a8", "name": "chromadb.chunk.1", "kind": "INTERNAL", "start_time": 1755774987632263800, "end_time": 1755774987632330400, "duration_ns": 66600, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 1, "chunk.node_id": "3bd1baa0-935f-4ffb-8ecf-1bf60006f499", "chunk.score": 0.48970473038442924, "chunk.title": "Untitled Document", "chunk.type": "testing_methodology", "chunk.text_length": 357, "chunk.has_embedding": false, "chunk.metadata.file_name": "test_urs.txt", "chunk.metadata.file_path": "tests\\test_data\\test_urs.txt", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.687328+00:00", "chunk.metadata.type": "testing_methodology", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "5", "chunk.metadata.test_types": "performance_testing,security_testing,validation_testing", "chunk.metadata.sections": "1. User authentication required,2. Data integrity (ALCOA+ compliance),3. Audit trail logging,4. Electronic signatures", "chunk.metadata.document_title": "Here\u2019s a refined and comprehensive title that incorporates all critical elements while maintaining clarity and conciseness:  \n\n**\"Validation and Testing of a High-Risk Custom Pharmaceutical System: Ensuring ALCOA+ Compliance, Secure User Authentication, Audit Trails, and Electronic Signatures through Rigorous Functional, Performance, and Security Testing (GAMP Category 5)\"**  \n\n### Key Improvements:  \n1. **Structure** \u2013 Opens with the scope (*Validation and Testing*) and system type (*High-Risk Custom Pharmaceutical System*).  \n2. **Compliance Focus** \u2013 Explicitly highlights *ALCOA+* as the core framework.  \n3. **Functional Requirements** \u2013 Bundles *User Authentication, Audit Trails, and Electronic Signatures* as critical features.  \n4. **Testing Rigor** \u2013 Emphasizes *Functional, Performance, and Security Testing* as validation pillars.  \n5. **Regulatory Context** \u2013 Closes with *(GAMP Category 5)* to anchor the high-risk classification.  \n\nThis version balances technical precision with readability, ensuring alignment with regulatory expectations (e.g., FDA 21 CFR Part 11, EU Annex 11) while targeting stakeholders in validation, IT, and quality assurance.  \n\nWould you like further adjustments to emphasize specific aspects (e.g., risk management, scalability)?", "chunk.metadata.excerpt_keywords": "Validation, ALCOA+, User Authentication, Audit Trails, Electronic Signatures, GAMP Category 5, Performance Testing, Security Testing, Pharmaceutical System, Regulatory Compliance"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.632392", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "a75216a6d5d46ba4", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "68bc21befb1a66a8", "name": "chromadb.chunk.2", "kind": "INTERNAL", "start_time": 1755774987633167100, "end_time": 1755774987633220900, "duration_ns": 53800, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 2, "chunk.node_id": "81aefa78-eb80-409b-88be-8c75d6858ce0", "chunk.score": 0.4769541150233713, "chunk.title": "Untitled Document", "chunk.type": "testing_methodology", "chunk.text_length": 469, "chunk.has_embedding": false, "chunk.metadata.file_name": "test_urs_hitl.txt", "chunk.metadata.file_path": "tests\\test_data\\test_urs_hitl.txt", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.689228+00:00", "chunk.metadata.type": "testing_methodology", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "5", "chunk.metadata.test_types": "performance_testing,security_testing,validation_testing", "chunk.metadata.sections": "1. User authentication required,2. Data integrity (ALCOA+ compliance),3. Audit trail logging,4. Electronic signatures", "chunk.metadata.document_title": "**\"High-Risk Custom Pharmaceutical System: Ensuring GAMP 5 Compliance with ALCOA+ Data Integrity, Robust User Authentication, Comprehensive Audit Trails, Secure Electronic Signatures, and Full-Scale Validation, Performance, and Security Testing\"**  \n\nThis comprehensive title encapsulates:  \n- **Risk Level (High)**  \n- **GAMP Category (5 - Custom Application)**  \n- **Key Functional Requirements** (ALCOA+ Data Integrity, User Authentication, Audit Trails, Electronic Signatures)  \n- **Testing Requirements** (Validation, Performance, Security Testing)  \n- **HITL (Human-in-the-Loop) Test Trigger** for scenario-based evaluation.  \n\nThe title is designed to provide clarity and precision for stakeholders in pharmaceutical compliance, software validation, and regulatory adherence.", "chunk.metadata.excerpt_keywords": "GAMP 5, ALCOA+, pharmaceutical compliance, custom application, high-risk system, user authentication, audit trail, electronic signatures, validation testing, security testing"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.633257", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "61f5901708116ee8", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "68bc21befb1a66a8", "name": "chromadb.chunk.3", "kind": "INTERNAL", "start_time": 1755774987633723800, "end_time": 1755774987633771500, "duration_ns": 47700, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 3, "chunk.node_id": "5b70b237-3851-43d3-942f-604651381597", "chunk.score": 0.45425468888261966, "chunk.title": "Untitled Document", "chunk.type": "testing_methodology", "chunk.text_length": 4009, "chunk.has_embedding": false, "chunk.metadata.file_name": "test_pharmaceutical_urs.txt", "chunk.metadata.file_path": "tests\\test_data\\test_pharmaceutical_urs.txt", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.685423+00:00", "chunk.metadata.type": "testing_methodology", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "4,5", "chunk.metadata.test_types": "performance_testing", "chunk.metadata.sections": "1. Sample Management and Chain of Custody,2. Test Method Management,3. Quality Control and Release,4. Regulatory Compliance Features,5. Integration Requirements", "chunk.metadata.document_title": "A comprehensive and precise title for your document could be:  \n\n**\"Comprehensive User Requirements Specification (URS) for a Customized Laboratory Information Management System (LIMS) in FDA-Regulated Pharmaceutical Manufacturing: Ensuring Compliance with 21 CFR Part 11, ALCOA+ Principles, and GAMP 5 Guidelines\"**  \n\nThis title effectively captures:  \n- The document type (**User Requirements Specification - URS**)  \n- The system in focus (**Customized LIMS**)  \n- The industry context (**FDA-regulated pharmaceutical manufacturing**)  \n- Key compliance frameworks (**21 CFR Part 11, ALCOA+, GAMP 5**)  \n\nIf you prefer a slightly more concise version while retaining all critical elements, you could use:  \n\n**\"User Requirements Specification (URS) for a Pharmaceutical LIMS: Compliance with 21 CFR Part 11, ALCOA+, and GAMP 5 in FDA-Regulated Manufacturing\"**  \n\nBoth options ensure regulatory and technical clarity while maintaining readability. Let me know if you'd like further refinements!", "chunk.metadata.excerpt_keywords": "Keywords: LIMS, Pharmaceutical Validation, 21 CFR Part 11, GAMP-5, ALCOA+, FDA Compliance, Electronic Records, Data Integrity, Sample Management, Quality Control"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.633803", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "239193683708cac9", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "68bc21befb1a66a8", "name": "chromadb.chunk.4", "kind": "INTERNAL", "start_time": 1755774987634211800, "end_time": 1755774987634257400, "duration_ns": 45600, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 4, "chunk.node_id": "25774d54-c90c-4c9b-ab00-ebba95074b65", "chunk.score": 0.44686272018628603, "chunk.title": "Untitled Document", "chunk.type": "regulatory_guidance", "chunk.text_length": 5726, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.650626+00:00", "chunk.metadata.type": "regulatory_guidance", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**\"Pharmaceutical Computerized Systems Validation: A Comprehensive Guide to GAMP Category 3, 4, and 5 OQ Test Scripts with Real-World Examples for LIMS, MES, ERP, EBR, DMS, and Custom Security Modules \u2013 Integrating Risk-Based Testing, 21 CFR Part 11, GAMP 5, and ALCOA+ Compliance\"**  \n\nThis title effectively combines:  \n1. **Scope & Focus**: Pharmaceutical validation, GAMP 3-5, OQ test scripts.  \n2. **Content Type**: Practical examples across diverse systems (LIMS, MES, ERP, etc.).  \n3. **Key Themes**: Risk-based testing, regulatory compliance (21 CFR Part 11, GAMP 5), ALCOA+ data integrity.  \n4. **Unique Entities**: Explicit mention of critical modules (Batch Execution, E-Signatures, Audit Trails, etc.).  \n\n*Alternative Concise Version*:  \n**\"GAMP 3-5 Validation in Pharma: Risk-Based OQ Test Scripts for 21 CFR Part 11, ALCOA+, and Critical System Modules\"**  \n\nBoth versions ensure clarity, regulatory relevance, and practical applicability while balancing detail and readability.", "chunk.metadata.excerpt_keywords": "Here are 10 unique keywords for this document, formatted as comma-separated:  \n\n**Keywords**: GAMP validation, OQ test scripts, pharmaceutical compliance, 21 CFR Part 11, ALCOA+, risk-based testing, computerized systems, PID algorithm, performance testing, electronic batch records"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.634285", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "c1a063131dbd4589", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "68bc21befb1a66a8", "name": "chromadb.chunk.5", "kind": "INTERNAL", "start_time": 1755774987634715700, "end_time": 1755774987634761800, "duration_ns": 46100, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 5, "chunk.node_id": "0f4371af-dc06-4b2a-85ae-3dd6f2e3f392", "chunk.score": 0.4459338823697484, "chunk.title": "Untitled Document", "chunk.type": "regulatory_guidance", "chunk.text_length": 5573, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.650626+00:00", "chunk.metadata.type": "regulatory_guidance", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**\"Pharmaceutical Computerized Systems Validation: A Comprehensive Guide to GAMP Category 3, 4, and 5 OQ Test Scripts with Real-World Examples for LIMS, MES, ERP, EBR, DMS, and Custom Security Modules \u2013 Integrating Risk-Based Testing, 21 CFR Part 11, GAMP 5, and ALCOA+ Compliance\"**  \n\nThis title effectively combines:  \n1. **Scope & Focus**: Pharmaceutical validation, GAMP 3-5, OQ test scripts.  \n2. **Content Type**: Practical examples across diverse systems (LIMS, MES, ERP, etc.).  \n3. **Key Themes**: Risk-based testing, regulatory compliance (21 CFR Part 11, GAMP 5), ALCOA+ data integrity.  \n4. **Unique Entities**: Explicit mention of critical modules (Batch Execution, E-Signatures, Audit Trails, etc.).  \n\n*Alternative Concise Version*:  \n**\"GAMP 3-5 Validation in Pharma: Risk-Based OQ Test Scripts for 21 CFR Part 11, ALCOA+, and Critical System Modules\"**  \n\nBoth versions ensure clarity, regulatory relevance, and practical applicability while balancing detail and readability.", "chunk.metadata.excerpt_keywords": "GAMP 5, 21 CFR Part 11, OQ Test Scripts, Pharmaceutical Validation, Risk-Based Testing, ALCOA+, Computer Software Assurance, Electronic Signatures, Audit Trail, Data Integrity"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.634789", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "059e577e63dda7ce", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "68bc21befb1a66a8", "name": "chromadb.chunk.6", "kind": "INTERNAL", "start_time": 1755774987635249700, "end_time": 1755774987635335700, "duration_ns": 86000, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 6, "chunk.node_id": "c861432b-4379-4525-9bfb-e7b99e4db37b", "chunk.score": 0.4380896854247896, "chunk.title": "Untitled Document", "chunk.type": "regulatory_guidance", "chunk.text_length": 2833, "chunk.has_embedding": false, "chunk.metadata.file_name": "validation_data.md", "chunk.metadata.file_path": "tests\\test_data\\gamp5_test_data\\validation_data.md", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.691302+00:00", "chunk.metadata.type": "regulatory_guidance", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "", "chunk.metadata.test_types": "", "chunk.metadata.sections": "GAMP-5 Categorization - Validation Data,URS-V01: Manufacturing Execution System (MES),1. Introduction,2. Functional Requirements,3. Regulatory Requirements", "chunk.metadata.document_title": "**Comprehensive Guide to GAMP-5 Categorization, Validation, and Regulatory Compliance for GxP-Compliant Systems: EDMS, CTMS, PLC-Based Autoclave Controller, and Custom Encryption in Manufacturing, Chromatography, Clinical Trials, and Document Management**  \n\nThis title comprehensively captures the scope of the document, including:  \n- **GAMP-5 Categorization and Validation Requirements** for both custom and commercial systems.  \n- **Key GxP-Compliant Systems**: Electronic Document Management System (EDMS), Clinical Trial Management System (CTMS), and PLC-Based Autoclave Controller.  \n- **Custom Encryption (URS-CTMS-013)** for specific jurisdictional needs.  \n- **Regulatory Compliance** with standards such as 21 CFR Part 11, audit trails, and user access controls.  \n- **Functional and System Requirements** for integration, workflows, and process control across manufacturing, chromatography, clinical trials, and document management.", "chunk.metadata.excerpt_keywords": "GAMP-5, validation, regulatory compliance, GxP, EDMS, CTMS, autoclave controller, 21 CFR Part 11, encryption, PLC"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.635363", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "11f61e44c9dbb34d", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "68bc21befb1a66a8", "name": "chromadb.chunk.7", "kind": "INTERNAL", "start_time": 1755774987635773300, "end_time": 1755774987635818800, "duration_ns": 45500, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 7, "chunk.node_id": "855933ad-883d-4ecd-baf8-b34d2ce56d94", "chunk.score": 0.4332589203651332, "chunk.title": "Untitled Document", "chunk.type": "regulatory_guidance", "chunk.text_length": 6776, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.650626+00:00", "chunk.metadata.type": "regulatory_guidance", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**\"Pharmaceutical Computerized Systems Validation: A Comprehensive Guide to GAMP Category 3, 4, and 5 OQ Test Scripts with Real-World Examples for LIMS, MES, ERP, EBR, DMS, and Custom Security Modules \u2013 Integrating Risk-Based Testing, 21 CFR Part 11, GAMP 5, and ALCOA+ Compliance\"**  \n\nThis title effectively combines:  \n1. **Scope & Focus**: Pharmaceutical validation, GAMP 3-5, OQ test scripts.  \n2. **Content Type**: Practical examples across diverse systems (LIMS, MES, ERP, etc.).  \n3. **Key Themes**: Risk-based testing, regulatory compliance (21 CFR Part 11, GAMP 5), ALCOA+ data integrity.  \n4. **Unique Entities**: Explicit mention of critical modules (Batch Execution, E-Signatures, Audit Trails, etc.).  \n\n*Alternative Concise Version*:  \n**\"GAMP 3-5 Validation in Pharma: Risk-Based OQ Test Scripts for 21 CFR Part 11, ALCOA+, and Critical System Modules\"**  \n\nBoth versions ensure clarity, regulatory relevance, and practical applicability while balancing detail and readability.", "chunk.metadata.excerpt_keywords": "GAMP validation, OQ test scripts, pharmaceutical systems, 21 CFR Part 11, ALCOA+, computerized systems, risk-based testing, LIMS validation, GAMP categories, regulatory compliance"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.635844", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "f14050fe1948c067", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "68bc21befb1a66a8", "name": "chromadb.chunk.8", "kind": "INTERNAL", "start_time": 1755774987636218400, "end_time": 1755774987636262200, "duration_ns": 43800, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 8, "chunk.node_id": "b5003a9b-e944-419b-ab9f-db545db87a10", "chunk.score": 0.4328670082303556, "chunk.title": "Untitled Document", "chunk.type": "testing_methodology", "chunk.text_length": 2277, "chunk.has_embedding": false, "chunk.metadata.file_name": "test_urs_comprehensive.txt", "chunk.metadata.file_path": "tests\\test_data\\test_urs_comprehensive.txt", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.687328+00:00", "chunk.metadata.type": "testing_methodology", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "5", "chunk.metadata.test_types": "acceptance_testing,regression_testing", "chunk.metadata.sections": "1. USER AUTHENTICATION & ACCESS CONTROL,2. DATA INTEGRITY (ALCOA+ COMPLIANCE),3. ELECTRONIC SIGNATURES,4. AUDIT TRAIL SYSTEM,5. DATA BACKUP & RECOVERY", "chunk.metadata.document_title": "**\"Comprehensive Validation and Compliance Framework for a High-Risk Clinical Data Management System (CDMS): Ensuring ALCOA+ Data Integrity, 21 CFR Part 11 Compliance, GAMP 5 Standards, and Robust Security Protocols in Accordance with ISO 27001, HIPAA, and ICH E6 Guidelines\"**  \n\nThis title comprehensively encapsulates:  \n- **System Type**: Clinical Data Management System (CDMS)  \n- **Risk Level**: High-risk, GxP-impactful  \n- **Key Standards**: ALCOA+, 21 CFR Part 11, GAMP 5, ISO 27001, HIPAA, ICH E6  \n- **Core Themes**: Data integrity, electronic signatures, audit trails, security (encryption, MFA), validation (IQ/OQ/PQ), and performance metrics.  \n- **Unique Entities**: Multi-factor authentication, RBAC, audit trail immutability, backup/recovery (RTO/RPO), and compliance frameworks.  \n\nThe title emphasizes the system\u2019s regulatory rigor, risk management, and end-to-end operational requirements, ensuring clarity and alignment with industry standards.", "chunk.metadata.excerpt_keywords": "Here are 10 unique keywords for this document, formatted as comma-separated:  \n\n**Keywords**: Clinical Data Management System, ALCOA+ Compliance, 21 CFR Part 11, GAMP 5, Electronic Signatures, Audit Trail Immutability, Data Integrity, ISO 27001, HIPAA, Risk-Based Validation"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.636286", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "2ce8d623c0566bc4", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "68bc21befb1a66a8", "name": "chromadb.chunk.9", "kind": "INTERNAL", "start_time": 1755774987636665900, "end_time": 1755774987636712000, "duration_ns": 46100, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 9, "chunk.node_id": "fc56c7a3-26b3-4aa1-a873-bc51e871fc3d", "chunk.score": 0.43211128995928877, "chunk.title": "Untitled Document", "chunk.type": "regulatory_guidance", "chunk.text_length": 6821, "chunk.has_embedding": false, "chunk.metadata.file_name": "ISPE - GAMP 5_ A Risk-Based Approach to Compliant GxP Computerized_short.md", "chunk.metadata.file_path": "tests\\test_data\\ISPE - GAMP 5_ A Risk-Based Approach to Compliant GxP Computerized_short.md", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.624352+00:00", "chunk.metadata.type": "regulatory_guidance", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "1,2,3,4,5", "chunk.metadata.test_types": "integration_testing,system_testing,acceptance_testing,performance_testing,regression_testing", "chunk.metadata.sections": "ISPE GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition),1 Introduction,1.1 Rationale for GAMP 5 Second Edition,2 Key Concepts,2.1 Overview", "chunk.metadata.document_title": "**\"GAMP 5 Second Edition: Risk-Based Compliance, Innovation, and Lifecycle Management for GxP Computerized Systems in Pharma 4.0 \u2013 A Comprehensive Framework for Digital Transformation, Quality Risk Management, and Patient-Centric Quality Systems\"**  \n\nThis comprehensive title integrates all key elements:  \n- **Core Focus:** GAMP 5\u2019s risk-based approach to GxP compliance and lifecycle management.  \n- **Key Themes:** Patient safety, data integrity, Agile/iterative methods, and emerging technologies (AI/ML, blockchain, cloud).  \n- **Industry Alignment:** Integration with Pharma 4.0, digital maturity, and regulatory frameworks (ISO, ASTM, FDA).  \n- **Updated Scope:** Emphasis on supplier involvement, critical thinking, and lifecycle management within a QMS.  \n- **Comprehensive Framework:** Quality Risk Management (QRM), validation, specification, verification, and critical thinking in regulated environments.  \n\nIt reflects the document\u2019s blend of regulatory guidance, technological advancement, and patient-centric quality systems, aligning with both traditional and Agile methodologies.", "chunk.metadata.excerpt_keywords": "Here are 10 unique keywords for the document, formatted as comma-separated:  \n\n**Keywords:** GAMP 5, risk-based compliance, computerized systems validation, Pharma 4.0, quality risk management (QRM), supplier assessment, lifecycle management, data integrity, Agile methodologies, regulatory frameworks"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.636737", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "7df33db3a0569c19", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "68bc21befb1a66a8", "name": "chromadb.chunk.10", "kind": "INTERNAL", "start_time": 1755774987637141100, "end_time": 1755774987637185400, "duration_ns": 44300, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 10, "chunk.node_id": "4335e520-6d9a-4e7d-aa08-e5274638be63", "chunk.score": 0.4318850326495772, "chunk.title": "Untitled Document", "chunk.type": "testing_methodology", "chunk.text_length": 6108, "chunk.has_embedding": false, "chunk.metadata.file_name": "testing_data.md", "chunk.metadata.file_path": "tests\\test_data\\gamp5_test_data\\testing_data.md", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.690295+00:00", "chunk.metadata.type": "testing_methodology", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "", "chunk.metadata.test_types": "", "chunk.metadata.sections": "GAMP-5 Categorization - Testing Data,URS-001: Environmental Monitoring System (EMS),1. Introduction,2. Functional Requirements,3. Regulatory Requirements", "chunk.metadata.document_title": "\"Comprehensive Guide to GAMP-5 Categorization, Testing, and Advanced System Requirements for Environmental Monitoring, LIMS, MES, CDS, and Clinical Trial Management Systems in Pharmaceutical Operations\"", "chunk.metadata.excerpt_keywords": "GAMP-5, Environmental Monitoring System, LIMS, MES, CDS, Regulatory Requirements, Functional Requirements, Testing Methodology, Pharmaceutical Operations, Compliance Level"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.637210", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "68bc21befb1a66a8", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "ef1fbc8c87dc3adc", "name": "chromadb.search_collection.gamp5", "kind": "INTERNAL", "start_time": 1755774987090728000, "end_time": 1755774987637701100, "duration_ns": 546973100, "status": {"status_code": "UNSET", "description": null}, "attributes": {"collection.name": "gamp5", "collection.document_count": 71, "collection.nodes_retrieved": 10, "collection.retrieval_time_ms": 416.28900000000004}, "events": [{"name": "collection_search_complete", "timestamp": 1755774987637686500, "attributes": {"nodes_retrieved": 10, "retrieval_time_ms": 416.28900000000004, "top_score": 0.48970473038442924, "avg_score": 0.4481922073475599, "chunk_details": "[{\"rank\": 1, \"node_id\": \"3bd1baa0-935f-4ffb-8ecf-1bf60006f499\", \"score\": 0.48970473038442924, \"title\": \"Untitled Document\", \"type\": \"testing_methodology\", \"text_preview\": \"PHARMACEUTICAL SYSTEM REQUIREMENTS\\n\\nGAMP Category: Category 5 (Custom Application)\\nRisk Level: High\\n\\nFunctional Requirements:\\n1. User authentication required\\n2. Data integrity (ALCOA+ compliance)  \\n3.\", \"metadata\": {\"file_name\": \"test_urs.txt\", \"file_path\": \"tests\\\\test_data\\\\test_urs.txt\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.687328+00:00\", \"type\": \"testing_methodology\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"5\", \"test_types\": \"performance_testing,security_testing,validation_testing\", \"sections\": \"1. User authentication required,2. Data integrity (ALCOA+ compliance),3. Audit trail logging,4. Electronic signatures\", \"document_title\": \"Here\\u2019s a refined and comprehensive title that incorporates all critical elements while maintaining clarity and conciseness:  \\n\\n**\\\"Validation and Testing of a High-Risk Custom Pharmaceutical System: Ensuring ALCOA+ Compliance, Secure User Authentication, Audit Trails, and Electronic Signatures through Rigorous Functional, Performance, and Security Testing (GAMP Category 5)\\\"**  \\n\\n### Key Improvements:  \\n1. **Structure** \\u2013 Opens with the scope (*Validation and Testing*) and system type (*High-Risk Custom Pharmaceutical System*).  \\n2. **Compliance Focus** \\u2013 Explicitly highlights *ALCOA+* as the core framework.  \\n3. **Functional Requirements** \\u2013 Bundles *User Authentication, Audit Trails, and Electronic Signatures* as critical features.  \\n4. **Testing Rigor** \\u2013 Emphasizes *Functional, Performance, and Security Testing* as validation pillars.  \\n5. **Regulatory Context** \\u2013 Closes with *(GAMP Category 5)* to anchor the high-risk classification.  \\n\\nThis version balances technical precision with readability, ensuring alignment with regulatory expectations (e.g., FDA 21 CFR Part 11, EU Annex 11) while targeting stakeholders in validation, IT, and quality assurance.  \\n\\nWould you like further adjustments to emphasize specific aspects (e.g., risk management, scalability)?\", \"excerpt_keywords\": \"Validation, ALCOA+, User Authentication, Audit Trails, Electronic Signatures, GAMP Category 5, Performance Testing, Security Testing, Pharmaceutical System, Regulatory Compliance\"}, \"embedding_id\": null}, {\"rank\": 2, \"node_id\": \"81aefa78-eb80-409b-88be-8c75d6858ce0\", \"score\": 0.4769541150233713, \"title\": \"Untitled Document\", \"type\": \"testing_methodology\", \"text_preview\": \"PHARMACEUTICAL SYSTEM REQUIREMENTS\\n\\nGAMP Category: Category 5 (Custom Application)\\nRisk Level: High\\n\\nFunctional Requirements:\\n1. User authentication required\\n2. Data integrity (ALCOA+ compliance)  \\n3.\", \"metadata\": {\"file_name\": \"test_urs_hitl.txt\", \"file_path\": \"tests\\\\test_data\\\\test_urs_hitl.txt\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.689228+00:00\", \"type\": \"testing_methodology\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"5\", \"test_types\": \"performance_testing,security_testing,validation_testing\", \"sections\": \"1. User authentication required,2. Data integrity (ALCOA+ compliance),3. Audit trail logging,4. Electronic signatures\", \"document_title\": \"**\\\"High-Risk Custom Pharmaceutical System: Ensuring GAMP 5 Compliance with ALCOA+ Data Integrity, Robust User Authentication, Comprehensive Audit Trails, Secure Electronic Signatures, and Full-Scale Validation, Performance, and Security Testing\\\"**  \\n\\nThis comprehensive title encapsulates:  \\n- **Risk Level (High)**  \\n- **GAMP Category (5 - Custom Application)**  \\n- **Key Functional Requirements** (ALCOA+ Data Integrity, User Authentication, Audit Trails, Electronic Signatures)  \\n- **Testing Requirements** (Validation, Performance, Security Testing)  \\n- **HITL (Human-in-the-Loop) Test Trigger** for scenario-based evaluation.  \\n\\nThe title is designed to provide clarity and precision for stakeholders in pharmaceutical compliance, software validation, and regulatory adherence.\", \"excerpt_keywords\": \"GAMP 5, ALCOA+, pharmaceutical compliance, custom application, high-risk system, user authentication, audit trail, electronic signatures, validation testing, security testing\"}, \"embedding_id\": null}, {\"rank\": 3, \"node_id\": \"5b70b237-3851-43d3-942f-604651381597\", \"score\": 0.45425468888261966, \"title\": \"Untitled Document\", \"type\": \"testing_methodology\", \"text_preview\": \"PHARMACEUTICAL URS DOCUMENT - TEST VALIDATION SYSTEM\\n\\nDocument Name: Laboratory Information Management System (LIMS) \\nDocument Version: 2.1.0-VALIDATION\\nAuthor: Pharmaceutical Validation Team\\nDate: 20\", \"metadata\": {\"file_name\": \"test_pharmaceutical_urs.txt\", \"file_path\": \"tests\\\\test_data\\\\test_pharmaceutical_urs.txt\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.685423+00:00\", \"type\": \"testing_methodology\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"4,5\", \"test_types\": \"performance_testing\", \"sections\": \"1. Sample Management and Chain of Custody,2. Test Method Management,3. Quality Control and Release,4. Regulatory Compliance Features,5. Integration Requirements\", \"document_title\": \"A comprehensive and precise title for your document could be:  \\n\\n**\\\"Comprehensive User Requirements Specification (URS) for a Customized Laboratory Information Management System (LIMS) in FDA-Regulated Pharmaceutical Manufacturing: Ensuring Compliance with 21 CFR Part 11, ALCOA+ Principles, and GAMP 5 Guidelines\\\"**  \\n\\nThis title effectively captures:  \\n- The document type (**User Requirements Specification - URS**)  \\n- The system in focus (**Customized LIMS**)  \\n- The industry context (**FDA-regulated pharmaceutical manufacturing**)  \\n- Key compliance frameworks (**21 CFR Part 11, ALCOA+, GAMP 5**)  \\n\\nIf you prefer a slightly more concise version while retaining all critical elements, you could use:  \\n\\n**\\\"User Requirements Specification (URS) for a Pharmaceutical LIMS: Compliance with 21 CFR Part 11, ALCOA+, and GAMP 5 in FDA-Regulated Manufacturing\\\"**  \\n\\nBoth options ensure regulatory and technical clarity while maintaining readability. Let me know if you'd like further refinements!\", \"excerpt_keywords\": \"Keywords: LIMS, Pharmaceutical Validation, 21 CFR Part 11, GAMP-5, ALCOA+, FDA Compliance, Electronic Records, Data Integrity, Sample Management, Quality Control\"}, \"embedding_id\": null}, {\"rank\": 4, \"node_id\": \"25774d54-c90c-4c9b-ab00-ebba95074b65\", \"score\": 0.44686272018628603, \"title\": \"Untitled Document\", \"type\": \"regulatory_guidance\", \"text_preview\": \"Login: validuser/wrongpassword\\n   Expected: Access denied, \\\"Invalid credentials\\\"\\n   Actual: _______________\\n   \\n2. Login: wronguser/validpassword  \\n   Expected: Access denied, \\\"Invalid credentials\\\"\\n  \", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.650626+00:00\", \"type\": \"regulatory_guidance\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**\\\"Pharmaceutical Computerized Systems Validation: A Comprehensive Guide to GAMP Category 3, 4, and 5 OQ Test Scripts with Real-World Examples for LIMS, MES, ERP, EBR, DMS, and Custom Security Modules \\u2013 Integrating Risk-Based Testing, 21 CFR Part 11, GAMP 5, and ALCOA+ Compliance\\\"**  \\n\\nThis title effectively combines:  \\n1. **Scope & Focus**: Pharmaceutical validation, GAMP 3-5, OQ test scripts.  \\n2. **Content Type**: Practical examples across diverse systems (LIMS, MES, ERP, etc.).  \\n3. **Key Themes**: Risk-based testing, regulatory compliance (21 CFR Part 11, GAMP 5), ALCOA+ data integrity.  \\n4. **Unique Entities**: Explicit mention of critical modules (Batch Execution, E-Signatures, Audit Trails, etc.).  \\n\\n*Alternative Concise Version*:  \\n**\\\"GAMP 3-5 Validation in Pharma: Risk-Based OQ Test Scripts for 21 CFR Part 11, ALCOA+, and Critical System Modules\\\"**  \\n\\nBoth versions ensure clarity, regulatory relevance, and practical applicability while balancing detail and readability.\", \"excerpt_keywords\": \"Here are 10 unique keywords for this document, formatted as comma-separated:  \\n\\n**Keywords**: GAMP validation, OQ test scripts, pharmaceutical compliance, 21 CFR Part 11, ALCOA+, risk-based testing, computerized systems, PID algorithm, performance testing, electronic batch records\"}, \"embedding_id\": null}, {\"rank\": 5, \"node_id\": \"0f4371af-dc06-4b2a-85ae-3dd6f2e3f392\", \"score\": 0.4459338823697484, \"title\": \"Untitled Document\", \"type\": \"regulatory_guidance\", \"text_preview\": \"Recipe Management (15 test cases)\\n2. Batch Execution (25 test cases)\\n3. Electronic Signatures (10 test cases)\\n4. Audit Trail (12 test cases)\\n5. Reporting (8 test cases)\\n6. Integration (20 test cases)\\n\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.650626+00:00\", \"type\": \"regulatory_guidance\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**\\\"Pharmaceutical Computerized Systems Validation: A Comprehensive Guide to GAMP Category 3, 4, and 5 OQ Test Scripts with Real-World Examples for LIMS, MES, ERP, EBR, DMS, and Custom Security Modules \\u2013 Integrating Risk-Based Testing, 21 CFR Part 11, GAMP 5, and ALCOA+ Compliance\\\"**  \\n\\nThis title effectively combines:  \\n1. **Scope & Focus**: Pharmaceutical validation, GAMP 3-5, OQ test scripts.  \\n2. **Content Type**: Practical examples across diverse systems (LIMS, MES, ERP, etc.).  \\n3. **Key Themes**: Risk-based testing, regulatory compliance (21 CFR Part 11, GAMP 5), ALCOA+ data integrity.  \\n4. **Unique Entities**: Explicit mention of critical modules (Batch Execution, E-Signatures, Audit Trails, etc.).  \\n\\n*Alternative Concise Version*:  \\n**\\\"GAMP 3-5 Validation in Pharma: Risk-Based OQ Test Scripts for 21 CFR Part 11, ALCOA+, and Critical System Modules\\\"**  \\n\\nBoth versions ensure clarity, regulatory relevance, and practical applicability while balancing detail and readability.\", \"excerpt_keywords\": \"GAMP 5, 21 CFR Part 11, OQ Test Scripts, Pharmaceutical Validation, Risk-Based Testing, ALCOA+, Computer Software Assurance, Electronic Signatures, Audit Trail, Data Integrity\"}, \"embedding_id\": null}, {\"rank\": 6, \"node_id\": \"c861432b-4379-4525-9bfb-e7b99e4db37b\", \"score\": 0.4380896854247896, \"title\": \"Untitled Document\", \"type\": \"regulatory_guidance\", \"text_preview\": \"- **URS-CTMS-013**: Custom encryption beyond platform standards for certain jurisdictions.\\n\\n---\\n\\n## URS-V04: Electronic Document Management System (EDMS)\\n**Target Category**: 4 (Clear)\\n**System Type**\", \"metadata\": {\"file_name\": \"validation_data.md\", \"file_path\": \"tests\\\\test_data\\\\gamp5_test_data\\\\validation_data.md\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.691302+00:00\", \"type\": \"regulatory_guidance\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"\", \"test_types\": \"\", \"sections\": \"GAMP-5 Categorization - Validation Data,URS-V01: Manufacturing Execution System (MES),1. Introduction,2. Functional Requirements,3. Regulatory Requirements\", \"document_title\": \"**Comprehensive Guide to GAMP-5 Categorization, Validation, and Regulatory Compliance for GxP-Compliant Systems: EDMS, CTMS, PLC-Based Autoclave Controller, and Custom Encryption in Manufacturing, Chromatography, Clinical Trials, and Document Management**  \\n\\nThis title comprehensively captures the scope of the document, including:  \\n- **GAMP-5 Categorization and Validation Requirements** for both custom and commercial systems.  \\n- **Key GxP-Compliant Systems**: Electronic Document Management System (EDMS), Clinical Trial Management System (CTMS), and PLC-Based Autoclave Controller.  \\n- **Custom Encryption (URS-CTMS-013)** for specific jurisdictional needs.  \\n- **Regulatory Compliance** with standards such as 21 CFR Part 11, audit trails, and user access controls.  \\n- **Functional and System Requirements** for integration, workflows, and process control across manufacturing, chromatography, clinical trials, and document management.\", \"excerpt_keywords\": \"GAMP-5, validation, regulatory compliance, GxP, EDMS, CTMS, autoclave controller, 21 CFR Part 11, encryption, PLC\"}, \"embedding_id\": null}, {\"rank\": 7, \"node_id\": \"855933ad-883d-4ecd-baf8-b34d2ce56d94\", \"score\": 0.4332589203651332, \"title\": \"Untitled Document\", \"type\": \"regulatory_guidance\", \"text_preview\": \"# Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation\\n\\nOperational Qualification (OQ) test scripts form the backbone of pharmaceutical computerized systems validation, ensurin\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.650626+00:00\", \"type\": \"regulatory_guidance\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**\\\"Pharmaceutical Computerized Systems Validation: A Comprehensive Guide to GAMP Category 3, 4, and 5 OQ Test Scripts with Real-World Examples for LIMS, MES, ERP, EBR, DMS, and Custom Security Modules \\u2013 Integrating Risk-Based Testing, 21 CFR Part 11, GAMP 5, and ALCOA+ Compliance\\\"**  \\n\\nThis title effectively combines:  \\n1. **Scope & Focus**: Pharmaceutical validation, GAMP 3-5, OQ test scripts.  \\n2. **Content Type**: Practical examples across diverse systems (LIMS, MES, ERP, etc.).  \\n3. **Key Themes**: Risk-based testing, regulatory compliance (21 CFR Part 11, GAMP 5), ALCOA+ data integrity.  \\n4. **Unique Entities**: Explicit mention of critical modules (Batch Execution, E-Signatures, Audit Trails, etc.).  \\n\\n*Alternative Concise Version*:  \\n**\\\"GAMP 3-5 Validation in Pharma: Risk-Based OQ Test Scripts for 21 CFR Part 11, ALCOA+, and Critical System Modules\\\"**  \\n\\nBoth versions ensure clarity, regulatory relevance, and practical applicability while balancing detail and readability.\", \"excerpt_keywords\": \"GAMP validation, OQ test scripts, pharmaceutical systems, 21 CFR Part 11, ALCOA+, computerized systems, risk-based testing, LIMS validation, GAMP categories, regulatory compliance\"}, \"embedding_id\": null}, {\"rank\": 8, \"node_id\": \"b5003a9b-e944-419b-ab9f-db545db87a10\", \"score\": 0.4328670082303556, \"title\": \"Untitled Document\", \"type\": \"testing_methodology\", \"text_preview\": \"PHARMACEUTICAL SYSTEM REQUIREMENTS - COMPREHENSIVE TEST\\n\\nSystem Name: Clinical Data Management System (CDMS)\\nGAMP Category: Category 5 (Custom Application)\\nRisk Level: High\\nGxP Impact: Direct impact o\", \"metadata\": {\"file_name\": \"test_urs_comprehensive.txt\", \"file_path\": \"tests\\\\test_data\\\\test_urs_comprehensive.txt\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.687328+00:00\", \"type\": \"testing_methodology\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"5\", \"test_types\": \"acceptance_testing,regression_testing\", \"sections\": \"1. USER AUTHENTICATION & ACCESS CONTROL,2. DATA INTEGRITY (ALCOA+ COMPLIANCE),3. ELECTRONIC SIGNATURES,4. AUDIT TRAIL SYSTEM,5. DATA BACKUP & RECOVERY\", \"document_title\": \"**\\\"Comprehensive Validation and Compliance Framework for a High-Risk Clinical Data Management System (CDMS): Ensuring ALCOA+ Data Integrity, 21 CFR Part 11 Compliance, GAMP 5 Standards, and Robust Security Protocols in Accordance with ISO 27001, HIPAA, and ICH E6 Guidelines\\\"**  \\n\\nThis title comprehensively encapsulates:  \\n- **System Type**: Clinical Data Management System (CDMS)  \\n- **Risk Level**: High-risk, GxP-impactful  \\n- **Key Standards**: ALCOA+, 21 CFR Part 11, GAMP 5, ISO 27001, HIPAA, ICH E6  \\n- **Core Themes**: Data integrity, electronic signatures, audit trails, security (encryption, MFA), validation (IQ/OQ/PQ), and performance metrics.  \\n- **Unique Entities**: Multi-factor authentication, RBAC, audit trail immutability, backup/recovery (RTO/RPO), and compliance frameworks.  \\n\\nThe title emphasizes the system\\u2019s regulatory rigor, risk management, and end-to-end operational requirements, ensuring clarity and alignment with industry standards.\", \"excerpt_keywords\": \"Here are 10 unique keywords for this document, formatted as comma-separated:  \\n\\n**Keywords**: Clinical Data Management System, ALCOA+ Compliance, 21 CFR Part 11, GAMP 5, Electronic Signatures, Audit Trail Immutability, Data Integrity, ISO 27001, HIPAA, Risk-Based Validation\"}, \"embedding_id\": null}, {\"rank\": 9, \"node_id\": \"fc56c7a3-26b3-4aa1-a873-bc51e871fc3d\", \"score\": 0.43211128995928877, \"title\": \"Untitled Document\", \"type\": \"regulatory_guidance\", \"text_preview\": \"Testing should be:\\n\\n- **Risk-Based**: Testing effort should be focused on high-risk areas\\n- **Comprehensive**: Testing should cover all system functions and requirements\\n- **Documented**: Testing shou\", \"metadata\": {\"file_name\": \"ISPE - GAMP 5_ A Risk-Based Approach to Compliant GxP Computerized_short.md\", \"file_path\": \"tests\\\\test_data\\\\ISPE - GAMP 5_ A Risk-Based Approach to Compliant GxP Computerized_short.md\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.624352+00:00\", \"type\": \"regulatory_guidance\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"1,2,3,4,5\", \"test_types\": \"integration_testing,system_testing,acceptance_testing,performance_testing,regression_testing\", \"sections\": \"ISPE GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition),1 Introduction,1.1 Rationale for GAMP 5 Second Edition,2 Key Concepts,2.1 Overview\", \"document_title\": \"**\\\"GAMP 5 Second Edition: Risk-Based Compliance, Innovation, and Lifecycle Management for GxP Computerized Systems in Pharma 4.0 \\u2013 A Comprehensive Framework for Digital Transformation, Quality Risk Management, and Patient-Centric Quality Systems\\\"**  \\n\\nThis comprehensive title integrates all key elements:  \\n- **Core Focus:** GAMP 5\\u2019s risk-based approach to GxP compliance and lifecycle management.  \\n- **Key Themes:** Patient safety, data integrity, Agile/iterative methods, and emerging technologies (AI/ML, blockchain, cloud).  \\n- **Industry Alignment:** Integration with Pharma 4.0, digital maturity, and regulatory frameworks (ISO, ASTM, FDA).  \\n- **Updated Scope:** Emphasis on supplier involvement, critical thinking, and lifecycle management within a QMS.  \\n- **Comprehensive Framework:** Quality Risk Management (QRM), validation, specification, verification, and critical thinking in regulated environments.  \\n\\nIt reflects the document\\u2019s blend of regulatory guidance, technological advancement, and patient-centric quality systems, aligning with both traditional and Agile methodologies.\", \"excerpt_keywords\": \"Here are 10 unique keywords for the document, formatted as comma-separated:  \\n\\n**Keywords:** GAMP 5, risk-based compliance, computerized systems validation, Pharma 4.0, quality risk management (QRM), supplier assessment, lifecycle management, data integrity, Agile methodologies, regulatory frameworks\"}, \"embedding_id\": null}, {\"rank\": 10, \"node_id\": \"4335e520-6d9a-4e7d-aa08-e5274638be63\", \"score\": 0.4318850326495772, \"title\": \"Untitled Document\", \"type\": \"testing_methodology\", \"text_preview\": \"# GAMP-5 Categorization - Testing Data\\n\\nThis file contains a set of User Requirements Specifications (URS) to be used for **testing** the GAMP-5 categorization agent. The examples are designed to cove\", \"metadata\": {\"file_name\": \"testing_data.md\", \"file_path\": \"tests\\\\test_data\\\\gamp5_test_data\\\\testing_data.md\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.690295+00:00\", \"type\": \"testing_methodology\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"\", \"test_types\": \"\", \"sections\": \"GAMP-5 Categorization - Testing Data,URS-001: Environmental Monitoring System (EMS),1. Introduction,2. Functional Requirements,3. Regulatory Requirements\", \"document_title\": \"\\\"Comprehensive Guide to GAMP-5 Categorization, Testing, and Advanced System Requirements for Environmental Monitoring, LIMS, MES, CDS, and Clinical Trial Management Systems in Pharmaceutical Operations\\\"\", \"excerpt_keywords\": \"GAMP-5, Environmental Monitoring System, LIMS, MES, CDS, Regulatory Requirements, Functional Requirements, Testing Methodology, Pharmaceutical Operations, Compliance Level\"}, \"embedding_id\": null}]"}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.637740", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "5b5d3d438fe0a5e5", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "833f72f8a37641d8", "name": "chromadb.query", "kind": "INTERNAL", "start_time": 1755774987929975300, "end_time": 1755774987958756900, "duration_ns": 28781600, "status": {"status_code": "UNSET", "description": null}, "attributes": {"vector_db.operation": "query", "compliance.gamp5.vector_operation": true, "compliance.pharmaceutical": true, "data_integrity.vector_search": true, "chromadb.query.n_results": 10, "chromadb.query.status": "success", "chromadb.query.result_count": 0, "chromadb.query.avg_distance": 0}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.958880", "span_type": "vector_database", "database_type": "chromadb", "operation": "query", "result_count": 0, "avg_distance": 0}
{"span_id": "833f72f8a37641d8", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "ef1fbc8c87dc3adc", "name": "chromadb.search_collection.regulatory", "kind": "INTERNAL", "start_time": 1755774987638335700, "end_time": 1755774987960904800, "duration_ns": 322569100, "status": {"status_code": "UNSET", "description": null}, "attributes": {"collection.name": "regulatory", "collection.document_count": 0, "collection.nodes_retrieved": 0, "collection.retrieval_time_ms": 319.321}, "events": [{"name": "collection_search_complete", "timestamp": 1755774987960888500, "attributes": {"nodes_retrieved": 0, "retrieval_time_ms": 319.321, "top_score": 0.0, "avg_score": 0.0, "chunk_details": "[]"}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:27.960986", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "0640e9fb2c6f1f82", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "ac5356e8841f611d", "name": "chromadb.query", "kind": "INTERNAL", "start_time": 1755774988316806400, "end_time": 1755774988345808900, "duration_ns": 29002500, "status": {"status_code": "UNSET", "description": null}, "attributes": {"vector_db.operation": "query", "compliance.gamp5.vector_operation": true, "compliance.pharmaceutical": true, "data_integrity.vector_search": true, "chromadb.query.n_results": 10, "chromadb.query.status": "success", "chromadb.query.result_count": 0, "chromadb.query.avg_distance": 0}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:28.345912", "span_type": "vector_database", "database_type": "chromadb", "operation": "query", "result_count": 0, "avg_distance": 0}
{"span_id": "ac5356e8841f611d", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "ef1fbc8c87dc3adc", "name": "chromadb.search_collection.sops", "kind": "INTERNAL", "start_time": 1755774987961956200, "end_time": 1755774988347290000, "duration_ns": 385333800, "status": {"status_code": "UNSET", "description": null}, "attributes": {"collection.name": "sops", "collection.document_count": 0, "collection.nodes_retrieved": 0, "collection.retrieval_time_ms": 380.983}, "events": [{"name": "collection_search_complete", "timestamp": 1755774988347277800, "attributes": {"nodes_retrieved": 0, "retrieval_time_ms": 380.983, "top_score": 0.0, "avg_score": 0.0, "chunk_details": "[]"}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:28.347346", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "1262f251efd0b06b", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "60c4cf2193852a3d", "name": "chromadb.query", "kind": "INTERNAL", "start_time": 1755774989355610400, "end_time": 1755774989391206600, "duration_ns": 35596200, "status": {"status_code": "UNSET", "description": null}, "attributes": {"vector_db.operation": "query", "compliance.gamp5.vector_operation": true, "compliance.pharmaceutical": true, "data_integrity.vector_search": true, "chromadb.query.n_results": 10, "chromadb.query.status": "success", "chromadb.query.result_count": 8, "chromadb.query.avg_distance": 0.8248982951045036}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:29.391312", "span_type": "vector_database", "database_type": "chromadb", "operation": "query", "result_count": 8, "avg_distance": 0.8248982951045036}
{"span_id": "5ebfb17fb7aa34a6", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "60c4cf2193852a3d", "name": "chromadb.chunk.1", "kind": "INTERNAL", "start_time": 1755774989394493400, "end_time": 1755774989394550500, "duration_ns": 57100, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 1, "chunk.node_id": "055be98e-d369-4395-b0f1-fc1d3853c2cb", "chunk.score": 0.4558393164643264, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 6492, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:07:38.359212+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "Integrated GAMP\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\u202fCFR\u202fPart\u202f11 Security Compliance.", "chunk.metadata.excerpt_keywords": "OQ, GAMP\u202f5, 21\u202fCFR\u202fPart\u202f11, electronic batch record, data integrity, risk\u2011based testing, scripted testing, audit trail, performance qualification, validation framework"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:29.394591", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "6bec5b6dbeec48de", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "60c4cf2193852a3d", "name": "chromadb.chunk.2", "kind": "INTERNAL", "start_time": 1755774989395124600, "end_time": 1755774989395172900, "duration_ns": 48300, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 2, "chunk.node_id": "baa66ce3-6a40-44a3-817f-23798b6425d1", "chunk.score": 0.4474382220329482, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 6679, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:07:38.359212+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "Integrated GAMP\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\u202fCFR\u202fPart\u202f11 Security Compliance.", "chunk.metadata.excerpt_keywords": "Operational Qualification, GAMP, pharmaceutical validation, environmental monitoring, LIMS, HPLC, data integrity, 21\u202fCFR\u202fPart\u202f11, risk assessment, test scripts"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:29.395204", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "55c87fa61937191d", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "60c4cf2193852a3d", "name": "chromadb.chunk.3", "kind": "INTERNAL", "start_time": 1755774989395637300, "end_time": 1755774989395683500, "duration_ns": 46200, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 3, "chunk.node_id": "db20acd0-9443-40b7-bfb1-37515be07960", "chunk.score": 0.4449909812369321, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 6492, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:09:48.217837+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**Comprehensive OQ Test\u2011Script Guide for Pharmaceutical Computerized Systems \u2013 GAMP\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\u2011Control Algorithms, Data\u2011Analysis Performance, Multi\u2011System Automation Integration, Integrated Batch\u2011Workflow Validation, 21\u202fCFR\u202fPart\u202f11 Compliance, Test\u2011Format Strategies & Data\u2011Integrity Verification)**", "chunk.metadata.excerpt_keywords": "OQ test scripts, GAMP\u202f5, 21\u202fCFR\u202fPart\u202f11, data integrity, MES\u2011LIMS integration, Electronic Batch Record (EBR), performance testing, risk\u2011based validation, audit trail verification, critical process parameter monitoring"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:29.395712", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "0558b6eb16e84061", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "60c4cf2193852a3d", "name": "chromadb.chunk.4", "kind": "INTERNAL", "start_time": 1755774989396112400, "end_time": 1755774989396156800, "duration_ns": 44400, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 4, "chunk.node_id": "c31d1974-a063-4a60-a3dc-6405574b1df7", "chunk.score": 0.44398240170875386, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 6679, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:09:48.217837+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**Comprehensive OQ Test\u2011Script Guide for Pharmaceutical Computerized Systems \u2013 GAMP\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\u2011Control Algorithms, Data\u2011Analysis Performance, Multi\u2011System Automation Integration, Integrated Batch\u2011Workflow Validation, 21\u202fCFR\u202fPart\u202f11 Compliance, Test\u2011Format Strategies & Data\u2011Integrity Verification)**", "chunk.metadata.excerpt_keywords": "Operational Qualification, GAMP\u202f5, Pharmaceutical computerized systems validation, Category\u202f3 non\u2011configured systems, Category\u202f4 configured systems, Category\u202f5 custom software, Environmental Monitoring System testing, 21\u202fCFR\u202fPart\u202f11 compliance, Data integrity verification, Test script formats"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:29.396184", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "2b0ee8c008bb9073", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "60c4cf2193852a3d", "name": "chromadb.chunk.5", "kind": "INTERNAL", "start_time": 1755774989396657900, "end_time": 1755774989396702100, "duration_ns": 44200, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 5, "chunk.node_id": "72bd7c48-cfce-4768-ad65-7727b5b1f001", "chunk.score": 0.4410016896856852, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 6281, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:07:38.359212+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "Integrated GAMP\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\u202fCFR\u202fPart\u202f11 Security Compliance.", "chunk.metadata.excerpt_keywords": "Keywords: GAMP\u202f5, Operational Qualification, Pharmaceutical Validation, LIMS, MES, ERP, 21\u202fCFR\u202fPart\u202f11, Test Scripts, Configured Systems, Custom Systems"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:29.396727", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "36bceaf29561b832", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "60c4cf2193852a3d", "name": "chromadb.chunk.6", "kind": "INTERNAL", "start_time": 1755774989397099800, "end_time": 1755774989397143500, "duration_ns": 43700, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 6, "chunk.node_id": "0ef52e54-af27-4b6a-8232-986db2b4b453", "chunk.score": 0.43481514015439043, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 6281, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:09:48.217837+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**Comprehensive OQ Test\u2011Script Guide for Pharmaceutical Computerized Systems \u2013 GAMP\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\u2011Control Algorithms, Data\u2011Analysis Performance, Multi\u2011System Automation Integration, Integrated Batch\u2011Workflow Validation, 21\u202fCFR\u202fPart\u202f11 Compliance, Test\u2011Format Strategies & Data\u2011Integrity Verification)**", "chunk.metadata.excerpt_keywords": "Keywords: OQ\u2011test\u2011scripts, GAMP\u2011categories, LIMS\u2011validation, MES\u2011batch\u2011record, ERP\u2011quality\u2011module, Power\u2011Loss\u2011Recovery, Exploratory\u2011Testing, 21CFR\u2011Part\u201111, Custom\u2011Security\u2011module, Data\u2011Integrity\u2011verification"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:29.397169", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "a96c96b4b46356ad", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "60c4cf2193852a3d", "name": "chromadb.chunk.7", "kind": "INTERNAL", "start_time": 1755774989397557000, "end_time": 1755774989397600500, "duration_ns": 43500, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 7, "chunk.node_id": "60697cad-6835-47f0-b885-cd0e69ecc10c", "chunk.score": 0.42090352962720423, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 5246, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:07:38.359212+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "Integrated GAMP\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\u202fCFR\u202fPart\u202f11 Security Compliance.", "chunk.metadata.excerpt_keywords": "Operational Qualification, GAMP\u202f5, Security Module Validation, Authentication Testing, PID Control Algorithm, Performance Load Testing, Audit Trail Verification, Role\u2011Based Authorization, Data Integrity under Stress, Multi\u2011System Integration Testing"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:29.397625", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "f307f0afbf8e0867", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "60c4cf2193852a3d", "name": "chromadb.chunk.8", "kind": "INTERNAL", "start_time": 1755774989397995900, "end_time": 1755774989398039800, "duration_ns": 43900, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 8, "chunk.node_id": "0d555a4e-9db2-4eff-9ac1-b87d4422a59d", "chunk.score": 0.41862048167738836, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 5246, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:09:48.217837+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**Comprehensive OQ Test\u2011Script Guide for Pharmaceutical Computerized Systems \u2013 GAMP\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\u2011Control Algorithms, Data\u2011Analysis Performance, Multi\u2011System Automation Integration, Integrated Batch\u2011Workflow Validation, 21\u202fCFR\u202fPart\u202f11 Compliance, Test\u2011Format Strategies & Data\u2011Integrity Verification)**", "chunk.metadata.excerpt_keywords": "Keywords: OQ testing, GAMP5, LIMS security, PID control algorithm, performance testing, integration testing, data integrity, audit trail, multi-system automation, pharmaceutical validation"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:29.398065", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "60c4cf2193852a3d", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "ef1fbc8c87dc3adc", "name": "chromadb.search_collection.best_practices", "kind": "INTERNAL", "start_time": 1755774988347810200, "end_time": 1755774989398529000, "duration_ns": 1050718800, "status": {"status_code": "UNSET", "description": null}, "attributes": {"collection.name": "best_practices", "collection.document_count": 8, "collection.nodes_retrieved": 8, "collection.retrieval_time_ms": 942.553}, "events": [{"name": "collection_search_complete", "timestamp": 1755774989398520000, "attributes": {"nodes_retrieved": 8, "retrieval_time_ms": 942.553, "top_score": 0.4558393164643264, "avg_score": 0.4384489703234536, "chunk_details": "[{\"rank\": 1, \"node_id\": \"055be98e-d369-4395-b0f1-fc1d3853c2cb\", \"score\": 0.4558393164643264, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"Create batch order in MES\\n2. Transfer to LIMS for testing\\n3. Execute analyses in LIMS\\n4. Return results to MES\\n5. Trigger analytics calculations\\n6. Generate integrated batch report\\n\\nVerification Point\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:07:38.359212+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"Integrated GAMP\\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\\u202fCFR\\u202fPart\\u202f11 Security Compliance.\", \"excerpt_keywords\": \"OQ, GAMP\\u202f5, 21\\u202fCFR\\u202fPart\\u202f11, electronic batch record, data integrity, risk\\u2011based testing, scripted testing, audit trail, performance qualification, validation framework\"}, \"embedding_id\": null}, {\"rank\": 2, \"node_id\": \"baa66ce3-6a40-44a3-817f-23798b6425d1\", \"score\": 0.4474382220329482, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"# Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation\\n\\nOperational Qualification (OQ) test scripts form the backbone of pharmaceutical computerized systems validation, ensurin\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:07:38.359212+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"Integrated GAMP\\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\\u202fCFR\\u202fPart\\u202f11 Security Compliance.\", \"excerpt_keywords\": \"Operational Qualification, GAMP, pharmaceutical validation, environmental monitoring, LIMS, HPLC, data integrity, 21\\u202fCFR\\u202fPart\\u202f11, risk assessment, test scripts\"}, \"embedding_id\": null}, {\"rank\": 3, \"node_id\": \"db20acd0-9443-40b7-bfb1-37515be07960\", \"score\": 0.4449909812369321, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"Create batch order in MES\\n2. Transfer to LIMS for testing\\n3. Execute analyses in LIMS\\n4. Return results to MES\\n5. Trigger analytics calculations\\n6. Generate integrated batch report\\n\\nVerification Point\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:09:48.217837+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**Comprehensive OQ Test\\u2011Script Guide for Pharmaceutical Computerized Systems \\u2013 GAMP\\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\\u2011Control Algorithms, Data\\u2011Analysis Performance, Multi\\u2011System Automation Integration, Integrated Batch\\u2011Workflow Validation, 21\\u202fCFR\\u202fPart\\u202f11 Compliance, Test\\u2011Format Strategies & Data\\u2011Integrity Verification)**\", \"excerpt_keywords\": \"OQ test scripts, GAMP\\u202f5, 21\\u202fCFR\\u202fPart\\u202f11, data integrity, MES\\u2011LIMS integration, Electronic Batch Record (EBR), performance testing, risk\\u2011based validation, audit trail verification, critical process parameter monitoring\"}, \"embedding_id\": null}, {\"rank\": 4, \"node_id\": \"c31d1974-a063-4a60-a3dc-6405574b1df7\", \"score\": 0.44398240170875386, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"# Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation\\n\\nOperational Qualification (OQ) test scripts form the backbone of pharmaceutical computerized systems validation, ensurin\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:09:48.217837+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**Comprehensive OQ Test\\u2011Script Guide for Pharmaceutical Computerized Systems \\u2013 GAMP\\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\\u2011Control Algorithms, Data\\u2011Analysis Performance, Multi\\u2011System Automation Integration, Integrated Batch\\u2011Workflow Validation, 21\\u202fCFR\\u202fPart\\u202f11 Compliance, Test\\u2011Format Strategies & Data\\u2011Integrity Verification)**\", \"excerpt_keywords\": \"Operational Qualification, GAMP\\u202f5, Pharmaceutical computerized systems validation, Category\\u202f3 non\\u2011configured systems, Category\\u202f4 configured systems, Category\\u202f5 custom software, Environmental Monitoring System testing, 21\\u202fCFR\\u202fPart\\u202f11 compliance, Data integrity verification, Test script formats\"}, \"embedding_id\": null}, {\"rank\": 5, \"node_id\": \"72bd7c48-cfce-4768-ad65-7727b5b1f001\", \"score\": 0.4410016896856852, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"Power Loss Recovery\\n   - Start logging, interrupt power\\n   - Verify data recovery\\n   - Accept: No data loss\\n\\nPart B - Exploratory Testing:\\n- Various sampling rates\\n- Multiple sensor inputs\\n- Export fo\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:07:38.359212+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"Integrated GAMP\\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\\u202fCFR\\u202fPart\\u202f11 Security Compliance.\", \"excerpt_keywords\": \"Keywords: GAMP\\u202f5, Operational Qualification, Pharmaceutical Validation, LIMS, MES, ERP, 21\\u202fCFR\\u202fPart\\u202f11, Test Scripts, Configured Systems, Custom Systems\"}, \"embedding_id\": null}, {\"rank\": 6, \"node_id\": \"0ef52e54-af27-4b6a-8232-986db2b4b453\", \"score\": 0.43481514015439043, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"Power Loss Recovery\\n   - Start logging, interrupt power\\n   - Verify data recovery\\n   - Accept: No data loss\\n\\nPart B - Exploratory Testing:\\n- Various sampling rates\\n- Multiple sensor inputs\\n- Export fo\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:09:48.217837+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**Comprehensive OQ Test\\u2011Script Guide for Pharmaceutical Computerized Systems \\u2013 GAMP\\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\\u2011Control Algorithms, Data\\u2011Analysis Performance, Multi\\u2011System Automation Integration, Integrated Batch\\u2011Workflow Validation, 21\\u202fCFR\\u202fPart\\u202f11 Compliance, Test\\u2011Format Strategies & Data\\u2011Integrity Verification)**\", \"excerpt_keywords\": \"Keywords: OQ\\u2011test\\u2011scripts, GAMP\\u2011categories, LIMS\\u2011validation, MES\\u2011batch\\u2011record, ERP\\u2011quality\\u2011module, Power\\u2011Loss\\u2011Recovery, Exploratory\\u2011Testing, 21CFR\\u2011Part\\u201111, Custom\\u2011Security\\u2011module, Data\\u2011Integrity\\u2011verification\"}, \"embedding_id\": null}, {\"rank\": 7, \"node_id\": \"60697cad-6835-47f0-b885-cd0e69ecc10c\", \"score\": 0.42090352962720423, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"### Custom LIMS Security Module - Comprehensive Robust Format\\n\\nThis detailed script demonstrates the rigor required for custom-developed security functions:\\n\\n```\\nTest Script OQ-LIMS-001: User Access C\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:07:38.359212+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"Integrated GAMP\\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\\u202fCFR\\u202fPart\\u202f11 Security Compliance.\", \"excerpt_keywords\": \"Operational Qualification, GAMP\\u202f5, Security Module Validation, Authentication Testing, PID Control Algorithm, Performance Load Testing, Audit Trail Verification, Role\\u2011Based Authorization, Data Integrity under Stress, Multi\\u2011System Integration Testing\"}, \"embedding_id\": null}, {\"rank\": 8, \"node_id\": \"0d555a4e-9db2-4eff-9ac1-b87d4422a59d\", \"score\": 0.41862048167738836, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"### Custom LIMS Security Module - Comprehensive Robust Format\\n\\nThis detailed script demonstrates the rigor required for custom-developed security functions:\\n\\n```\\nTest Script OQ-LIMS-001: User Access C\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:09:48.217837+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**Comprehensive OQ Test\\u2011Script Guide for Pharmaceutical Computerized Systems \\u2013 GAMP\\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\\u2011Control Algorithms, Data\\u2011Analysis Performance, Multi\\u2011System Automation Integration, Integrated Batch\\u2011Workflow Validation, 21\\u202fCFR\\u202fPart\\u202f11 Compliance, Test\\u2011Format Strategies & Data\\u2011Integrity Verification)**\", \"excerpt_keywords\": \"Keywords: OQ testing, GAMP5, LIMS security, PID control algorithm, performance testing, integration testing, data integrity, audit trail, multi-system automation, pharmaceutical validation\"}, \"embedding_id\": null}]"}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:29.398560", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "ef1fbc8c87dc3adc", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": "4707497641fd5520", "name": "chromadb.search_documents", "kind": "INTERNAL", "start_time": 1755774985687367200, "end_time": 1755774989399183400, "duration_ns": 3711816200, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chromadb.query": "GAMP Category 4 validation testing functional_requirements validation_requirements", "chromadb.query_length": 82, "chromadb.query_embedding_time_ms": 1402.844, "chromadb.query_embedding_dimension": 1536, "chromadb.collections": "[\"gamp5\", \"regulatory\", \"sops\", \"best_practices\"]", "chromadb.collection_count": 4, "chromadb.gamp_category": "4", "chromadb.max_documents": 10, "chromadb.context_depth": "standard", "chromadb.search_scope": "{}", "chromadb.total_results": 18, "chromadb.final_results": 10, "chromadb.success": true, "chromadb.average_relevance_score": 0.45469627479751, "chromadb.top_relevance_score": 0.48970473038442924}, "events": [{"name": "query_generated", "timestamp": 1755774987090572000, "attributes": {"query_text": "GAMP Category 4 validation testing functional_requirements validation_requirements", "query_parts": "[\"GAMP\", \"Category\", \"4\", \"validation\", \"testing\", \"functional_requirements\", \"validation_requirements\"]", "embedding_time_ms": 1402.844, "embedding_norm": 0.999999994124102}}, {"name": "search_results_summary", "timestamp": 1755774989399165800, "attributes": {"total_documents": 10, "collections_searched": "[\"gamp5\", \"regulatory\", \"sops\", \"best_practices\"]", "document_types": "[\"best_practices\", \"testing_methodology\", \"regulatory_guidance\"]", "gamp_categories_found": "[\"4\", \"3\", \"5\"]"}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:29.399224", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "4707497641fd5520", "trace_id": "eebb98eaee7efd872a7b38951fc36e2c", "parent_id": null, "name": "context_provider.process_request", "kind": "INTERNAL", "start_time": 1755774985687098700, "end_time": 1755774989401466500, "duration_ns": 3714367800, "status": {"status_code": "UNSET", "description": null}, "attributes": {"agent.method": "process_request", "agent.module": "src.agents.parallel.context_provider", "agent.type": "context_provider", "operation": "process_request", "agent.class": "ContextProviderAgent", "request.gamp_category": "4", "request.context_depth": "standard", "request.correlation_id": "64425b7d-9b5d-4073-9e49-9237eaa7b5d2", "request.search_scope": "{}", "request.document_sections_count": 2, "request.timeout_seconds": 180, "request.test_types": "[]", "result.success": true, "result.documents_retrieved": 10, "result.context_quality": "low", "result.search_coverage": 0.0, "result.confidence_score": 0.401878509919004, "result.processing_time": 3.712757}, "events": [{"name": "context_quality_assessment", "timestamp": 1755774989399730500, "attributes": {"avg_relevance": 0.45469627479751, "section_coverage": 0.0, "required_sections": "[\"functional_requirements\", \"validation_requirements\"]", "covered_sections": "[\"Environmental Monitoring System - Robust Scripted Format\", \"1. User authentication required\", \"Understanding GAMP categories and their validation requirements\", \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation\", \"3. Audit trail logging\", \"1. Navigate to sensor configuration screen\", \"4. Electronic signatures\", \"4. Regulatory Compliance Features\", \"GAMP Category 3: Non-configured systems test scripts\", \"2. Test Method Management\", \"5. Integration Requirements\", \"3. Quality Control and Release\", \"2. Data integrity (ALCOA+ compliance)\", \"1. Sample Management and Chain of Custody\"]", "quality": "low"}}, {"name": "confidence_calculation", "timestamp": 1755774989399865700, "attributes": {"avg_relevance": 0.45469627479751, "search_coverage": 0.0, "context_quality": "low", "quality_factor": 0.6, "document_count": 10, "document_count_factor": 1.0, "final_confidence": 0.401878509919004}}, {"name": "documents_retrieved", "timestamp": 1755774989399954000, "attributes": {"document_count": 10, "top_document_titles": "[\"Untitled Document\", \"Untitled Document\", \"Untitled Document\", \"Untitled Document\", \"Untitled Document\"]", "average_relevance_score": 0.45469627479751}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:29.401520"}
{"span_id": "032c0666a23c97ab", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "77fd3ce5f1c58145", "name": "fda.drug_labels_search", "kind": "INTERNAL", "start_time": 1755774989410702700, "end_time": 1755774990851770900, "duration_ns": 1441068200, "status": {"status_code": "UNSET", "description": null}, "attributes": {"api.service": "fda", "api.endpoint": "drug_labels_search", "api.query": "computer software validation pharmaceutical", "api.limit": 3, "api.duration_seconds": 1.4410433769226074, "api.success": true, "api.results_count": 3}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:30.851862"}
{"span_id": "b9039e2ff01be7f2", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "77fd3ce5f1c58145", "name": "fda.enforcement_search", "kind": "INTERNAL", "start_time": 1755774990853349200, "end_time": 1755775004859938100, "duration_ns": 14006588900, "status": {"status_code": "UNSET", "description": null}, "attributes": {"api.service": "fda", "api.endpoint": "enforcement_search", "api.query": "computer software validation pharmaceutical", "api.limit": 2, "api.duration_seconds": 14.00662612915039, "api.success": true, "api.results_count": 2}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:44.860039"}
{"span_id": "b3d0e72e48422bde", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "77fd3ce5f1c58145", "name": "fda.drug_labels_search", "kind": "INTERNAL", "start_time": 1755775004860699200, "end_time": 1755775019857184400, "duration_ns": 14996485200, "status": {"status_code": "UNSET", "description": null}, "attributes": {"api.service": "fda", "api.endpoint": "drug_labels_search", "api.query": "pharmaceutical Category 4", "api.limit": 3, "api.duration_seconds": 14.996533632278442, "api.success": true, "api.results_count": 3}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:16:59.857262"}
{"span_id": "e779de38618edf9d", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "77fd3ce5f1c58145", "name": "fda.enforcement_search", "kind": "INTERNAL", "start_time": 1755775019858370700, "end_time": 1755775034893947100, "duration_ns": 15035576400, "status": {"status_code": "UNSET", "description": null}, "attributes": {"api.service": "fda", "api.endpoint": "enforcement_search", "api.query": "pharmaceutical Category 4", "api.limit": 2, "api.duration_seconds": 15.03564190864563, "api.success": true, "api.results_count": 2}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:14.894105"}
{"span_id": "df91902eba0cf1fa", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "77fd3ce5f1c58145", "name": "fda.drug_labels_search", "kind": "INTERNAL", "start_time": 1755775034895305700, "end_time": 1755775050416121800, "duration_ns": 15520816100, "status": {"status_code": "UNSET", "description": null}, "attributes": {"api.service": "fda", "api.endpoint": "drug_labels_search", "api.query": "pharmaceutical OQ testing", "api.limit": 3, "api.duration_seconds": 15.520860433578491, "api.success": true, "api.results_count": 3}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:30.416283"}
{"span_id": "84b0064b71ad8cdf", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "77fd3ce5f1c58145", "name": "fda.enforcement_search", "kind": "INTERNAL", "start_time": 1755775050427827100, "end_time": 1755775064755306000, "duration_ns": 14327478900, "status": {"status_code": "UNSET", "description": null}, "attributes": {"api.service": "fda", "api.endpoint": "enforcement_search", "api.query": "pharmaceutical OQ testing", "api.limit": 2, "api.duration_seconds": 14.327630281448364, "api.success": true, "api.results_count": 2}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:44.755382"}
{"span_id": "77fd3ce5f1c58145", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "94816f489b81f84d", "name": "research.regulatory_updates", "kind": "INTERNAL", "start_time": 1755774989410669000, "end_time": 1755775064756311500, "duration_ns": 75345642500, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:44.756334"}
{"span_id": "fd0bc3c9f0645e96", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "94816f489b81f84d", "name": "research.best_practices", "kind": "INTERNAL", "start_time": 1755775064756604000, "end_time": 1755775064756653300, "duration_ns": 49300, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:44.756670"}
{"span_id": "7cdd296313c0cc21", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "94816f489b81f84d", "name": "research.industry_trends", "kind": "INTERNAL", "start_time": 1755775064756859900, "end_time": 1755775064756895300, "duration_ns": 35400, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:44.756911"}
{"span_id": "4cf6e5e4e921dd02", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "94816f489b81f84d", "name": "research.compile_results", "kind": "INTERNAL", "start_time": 1755775064757122800, "end_time": 1755775064757162200, "duration_ns": 39400, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:44.757176"}
{"span_id": "35fe8498760a35fb", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "94816f489b81f84d", "name": "research.generate_guidance", "kind": "INTERNAL", "start_time": 1755775064757361000, "end_time": 1755775064757402300, "duration_ns": 41300, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:44.757416"}
{"span_id": "756fb35de9232266", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "94816f489b81f84d", "name": "research.analyze_compliance", "kind": "INTERNAL", "start_time": 1755775064757581300, "end_time": 1755775064762201600, "duration_ns": 4620300, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:44.762270"}
{"span_id": "94816f489b81f84d", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": "6a4d297820fc6af5", "name": "research.execute", "kind": "INTERNAL", "start_time": 1755774989410612100, "end_time": 1755775064762863600, "duration_ns": 75352251500, "status": {"status_code": "UNSET", "description": null}, "attributes": {"research.request_id": "5842ddbd-7831-4603-a9af-3a2c27afed05", "research.depth_level": "comprehensive", "research.regulatory_updates_count": 6, "research.best_practices_count": 2, "research.industry_trends_count": 4, "research.total_results": 12, "research.guidance_summaries_count": 3, "research.quality": "low", "research.confidence_score": 0.6593333333333333, "research.strategy": "comprehensive_multi_source", "research.sources_count": 6}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:44.762897"}
{"span_id": "6a4d297820fc6af5", "trace_id": "f32d8170858eb4352e4b12a8f124ab30", "parent_id": null, "name": "research_agent.process_request", "kind": "INTERNAL", "start_time": 1755774989410433200, "end_time": 1755775064763780200, "duration_ns": 75353347000, "status": {"status_code": "UNSET", "description": null}, "attributes": {"agent.method": "process_request", "agent.module": "src.agents.parallel.research_agent", "agent.type": "research_agent", "operation": "process_request", "agent.class": "ResearchAgent", "request.correlation_id": "5842ddbd-7831-4603-a9af-3a2c27afed05", "request.research_focus": "['GAMP-5', 'Category 4', 'OQ testing']", "request.regulatory_scope": "['FDA', 'EMA', 'ICH']", "request.depth_level": "comprehensive", "request.time_horizon": "current", "request.include_trends": true, "request.timeout_seconds": 240, "compliance.gamp5.research": true, "compliance.pharmaceutical": true, "result.results_count": 12, "result.regulatory_updates_count": 6, "result.best_practices_count": 2, "result.industry_trends_count": 4, "result.confidence_score": 0.6593333333333333, "result.research_quality": "low", "result.processing_time_seconds": 75.352627, "result.success": true}, "events": [{"name": "research_analysis_start", "timestamp": 1755774989410562900, "attributes": {"research_focus_count": 3, "regulatory_scope_count": 3, "depth_level": "comprehensive", "time_horizon": "current"}}, {"name": "research_analysis_complete", "timestamp": 1755775064763144700, "attributes": {"results_count": 12, "regulatory_updates_count": 6, "best_practices_count": 2, "confidence_score": 0.6593333333333333, "research_quality": "low", "processing_time": 75.352627}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:44.763881"}
{"span_id": "f123f07a0ac355c2", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "4a49f2e31f903af4", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775064776554400, "end_time": 1755775067867211600, "duration_ns": 3090657200, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('\\n        As a pharmaceutical validation expert specializing in GAMP Category 4, assess the compliance requirements for a system with the following characteristics:\\n        \\n        - Specialty: GAMP Category 4\\n        - Compliance Level: high\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        - GAMP Category: unknown\\n        - Confidence Score: 0.0\\n        - Domain Knowledge Areas: \\n        - Validation Focus: enhanced\\n        \\n        Provide a comprehensive compliance assessment including:\\n        1. Applicable regulatory standards\\n        2. Compliance gaps that need attention\\n        3. Required controls for this GAMP category\\n        4. Certainty score (0.0-1.0) for this assessment\\n        \\n        Respond with valid JSON in this exact format:\\n        {\\n            \"level\": \"compliance_level\",\\n            \"applicable_standards\": [\"standard1\", \"standard2\"],\\n            \"compliance_gaps\": [{\"gap\": \"description\", \"impact\": \"high/medium/low\", \"recommendation\": \"action\"}],\\n            \"required_controls\": [\"control1\", \"control2\"],\\n            \"certainty_score\": 0.0\\n        }\\n        ',)", "input.value": "\n        As a pharmaceutical validation expert specializing in GAMP Category 4, assess the compliance requirements for a system with the following characteristics:\n        \n        - Specialty: GAMP Category 4\n        - Compliance Level: high\n        - Test Focus: OQ testing for pharmaceutical compliance\n        - GAMP Category: unknown\n        - Confidence Score: 0.0\n        - Domain Knowledge Areas: \n        - Validation Focus: enhanced\n        \n        Provide a comprehensive compliance assessment including:\n        1. Applicable regulatory standards\n        2. Compliance gaps that need attention\n        3. Required controls for this GAMP category\n        4. Certainty score (0.0-1.0) for this assessment\n        \n        Respond with valid JSON in this exact format:\n        {\n            \"level\": \"compliance_level\",\n            \"applicable_standards\": [\"standard1\", \"standard2\"],\n            \"compliance_gaps\": [{\"gap\": \"description\", \"impact\": \"high/medium/low\", \"recommendation\": \"action\"}],\n            \"required_controls\": [\"control1\", \"control2\"],\n            \"certainty_score\": 0.0\n        }\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "```json\n{\n    \"level\": \"high\",\n    \"applicable_standards\": [\"FDA 21 CFR Part 11\", \"EU Annex 11\", \"ICH Q7\", \"GAMP 5\"],\n    \"compliance_gaps\": [\n        {\n            \"gap\": \"Unknown GAMP Category\",\n            \"impact\": \"high\",\n            \"recommendation\": \"Determine the correct GAMP Category based on system complexity and intended use.\"\n        },\n        {\n            \"gap\": \"Confidence Score of 0.0 indicates insufficient data for assessment\",\n            \"impact\": \"high\",\n            \"recommendation\": \"Gather additional system details and validation documentation to improve assessment accuracy.\"\n        }\n    ],\n    \"required_controls\": [\n        \"Detailed risk assessment and mitigation strategies\",\n        \"Comprehensive OQ testing protocols\",\n        \"Documented evidence of system validation\",\n        \"Periodic review and revalidation procedures\"\n    ],\n    \"certainty_score\": 0.0\n}\n```", "llm.token_count.prompt": 280, "llm.token_count.completion": 225, "llm.token_count.total": 505, "llm.latency_ms": 3090.39306640625}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:47.867311", "span_type": "llm", "prompt_tokens": 280, "completion_tokens": 225, "model": "deepseek/deepseek-chat"}
{"span_id": "4a49f2e31f903af4", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "9ba89121294d6f65", "name": "sme.compliance_assessment", "kind": "INTERNAL", "start_time": 1755775064776359800, "end_time": 1755775067868380900, "duration_ns": 3092021100, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:47.868405"}
{"span_id": "f45c124abaa1f6ee", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "efa66d90d8e48e12", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775067868919800, "end_time": 1755775078015144500, "duration_ns": 10146224700, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('\\n        As a pharmaceutical validation expert, analyze the validation risks for a system with these characteristics:\\n        \\n        - Specialty: GAMP Category 4\\n        - Compliance Level: high\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        - Risk Factors: {}\\n        - Validation Focus: enhanced\\n        - GAMP Category: unknown\\n        \\n        Provide a comprehensive risk analysis including:\\n        1. Identified risks with categories, probability, and impact\\n        2. Overall risk level assessment\\n        3. Specific mitigation strategies\\n        4. Critical concerns requiring immediate attention\\n        5. Clarity score (0.0-1.0) for the risk assessment\\n        \\n        Consider pharmaceutical validation risks including:\\n        - Technical complexity and integration risks\\n        - Regulatory compliance gaps\\n        - Data integrity concerns (ALCOA+ principles)\\n        - Validation lifecycle risks\\n        - Change control and configuration management\\n        \\n        Respond with valid JSON in this exact format:\\n        {\\n            \"identified_risks\": [\\n                {\\n                    \"category\": \"category_name\",\\n                    \"risk\": \"risk_description\", \\n                    \"probability\": \"low/medium/high\",\\n                    \"impact\": \"low/medium/high/critical\",\\n                    \"mitigation\": \"mitigation_strategy\"\\n                }\\n            ],\\n            \"risk_level\": \"critical/high/medium/low\",\\n            \"mitigation_strategies\": [\\n                {\\n                    \"strategy\": \"strategy_description\",\\n                    \"priority\": \"critical/high/medium/low\", \\n                    \"timeline\": \"immediate/planned/future\"\\n                }\\n            ],\\n            \"critical_concerns\": [\"concern1\", \"concern2\"],\\n            \"clarity_score\": 0.0\\n        }\\n        ',)", "input.value": "\n        As a pharmaceutical validation expert, analyze the validation risks for a system with these characteristics:\n        \n        - Specialty: GAMP Category 4\n        - Compliance Level: high\n        - Test Focus: OQ testing for pharmaceutical compliance\n        - Risk Factors: {}\n        - Validation Focus: enhanced\n        - GAMP Category: unknown\n        \n        Provide a comprehensive risk analysis including:\n        1. Identified risks with categories, probability, and impact\n        2. Overall risk level assessment\n        3. Specific mitigation strategies\n        4. Critical concerns requiring immediate attention\n        5. Clarity score (0.0-1.0) for the risk assessment\n        \n        Consider pharmaceutical validation risks including:\n        - Technical complexity and integration risks\n        - Regulatory compliance gaps\n        - Data integrity concerns (ALCOA+ principles)\n        - Validation lifecycle risks\n        - Change control and configuration management\n        \n        Respond with valid JSON in this exact format:\n        {\n            \"identified_risks\": [\n                {\n                    \"category\": \"category_name\",\n                    \"risk\": \"risk_description\", \n                    \"probability\": \"low/medium/high\",\n                    \"impact\": \"low/medium/high/critical\",\n                    \"mitigation\": \"mitigation_strategy\"\n                }\n            ],\n            \"risk_level\": \"critical/high/medium/low\",\n            \"mitigation_strategies\": [\n                {\n                    \"strategy\": \"strategy_description\",\n                    \"priority\": \"critical/high/medium/low\", \n                    \"timeline\": \"immediate/planned/future\"\n                }\n            ],\n            \"critical_concerns\": [\"concern1\", \"concern2\"],\n            \"clarity_score\": 0.0\n        }\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "```json\n{\n    \"identified_risks\": [\n        {\n            \"category\": \"Regulatory Compliance\",\n            \"risk\": \"Potential gaps in meeting high compliance level requirements due to unknown GAMP category\", \n            \"probability\": \"medium\",\n            \"impact\": \"critical\",\n            \"mitigation\": \"Conduct a detailed GAMP category assessment and align validation activities with regulatory expectations\"\n        },\n        {\n            \"category\": \"Data Integrity\",\n            \"risk\": \"Risk of non-compliance with ALCOA+ principles during OQ testing\", \n            \"probability\": \"high\",\n            \"impact\": \"critical\",\n            \"mitigation\": \"Implement robust data integrity controls and audit trails during OQ testing\"\n        },\n        {\n            \"category\": \"Technical Complexity\",\n            \"risk\": \"Integration risks due to the complexity of GAMP Category 4 systems\", \n            \"probability\": \"high\",\n            \"impact\": \"high\",\n            \"mitigation\": \"Perform thorough integration testing and ensure proper documentation of interfaces\"\n        },\n        {\n            \"category\": \"Validation Lifecycle\",\n            \"risk\": \"Inadequate validation lifecycle management due to enhanced validation focus\", \n            \"probability\": \"medium\",\n            \"impact\": \"high\",\n            \"mitigation\": \"Develop a comprehensive validation plan covering all lifecycle phases and ensure stakeholder alignment\"\n        },\n        {\n            \"category\": \"Change Control\",\n            \"risk\": \"Insufficient configuration management leading to validation gaps\", \n            \"probability\": \"medium\",\n            \"impact\": \"high\",\n            \"mitigation\": \"Establish a robust change control process and maintain a configuration management database\"\n        }\n    ],\n    \"risk_level\": \"high\",\n    \"mitigation_strategies\": [\n        {\n            \"strategy\": \"Conduct a GAMP category assessment to clarify system classification\",\n            \"priority\": \"critical\", \n            \"timeline\": \"immediate\"\n        },\n        {\n            \"strategy\": \"Implement ALCOA+ compliant data integrity controls during OQ testing\",\n            \"priority\": \"critical\", \n            \"timeline\": \"immediate\"\n        },\n        {\n            \"strategy\": \"Perform integration testing and document interfaces thoroughly\",\n            \"priority\": \"high\", \n            \"timeline\": \"planned\"\n        },\n        {\n            \"strategy\": \"Develop a comprehensive validation plan covering all lifecycle phases\",\n            \"priority\": \"high\", \n            \"timeline\": \"planned\"\n        },\n        {\n            \"strategy\": \"Establish a robust change control process and maintain a configuration management database\",\n            \"priority\": \"medium\", \n            \"timeline\": \"future\"\n        }\n    ],\n    \"critical_concerns\": [\n        \"Unknown GAMP category leading to potential regulatory compliance gaps\",\n        \"Risk of non-compliance with ALCOA+ principles during OQ testing\"\n    ],\n    \"clarity_score\": 0.8\n}\n```", "llm.token_count.prompt": 462, "llm.token_count.completion": 756, "llm.token_count.total": 1218, "llm.latency_ms": 10145.936489105225}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:58.015365", "span_type": "llm", "prompt_tokens": 462, "completion_tokens": 756, "model": "deepseek/deepseek-chat"}
{"span_id": "efa66d90d8e48e12", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "9ba89121294d6f65", "name": "sme.risk_analysis", "kind": "INTERNAL", "start_time": 1755775067868688700, "end_time": 1755775078016736000, "duration_ns": 10148047300, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:17:58.016760"}
{"span_id": "60e9dff854ef2838", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "53ebe51eb6b4d726", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775078017392300, "end_time": 1755775087471904300, "duration_ns": 9454512000, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('\\n        As a pharmaceutical validation expert specializing in GAMP Category 4, generate specific recommendations based on this analysis:\\n        \\n        COMPLIANCE ASSESSMENT:\\n        {\\'level\\': \\'high\\', \\'applicable_standards\\': [\\'FDA 21 CFR Part 11\\', \\'EU Annex 11\\', \\'ICH Q7\\', \\'GAMP 5\\'], \\'compliance_gaps\\': [{\\'gap\\': \\'Unknown GAMP Category\\', \\'impact\\': \\'high\\', \\'recommendation\\': \\'Determine the correct GAMP Category based on system complexity and intended use.\\'}, {\\'gap\\': \\'Confidence Score of 0.0 indicates insufficient data for assessment\\', \\'impact\\': \\'high\\', \\'recommendation\\': \\'Gather additional system details and validation documentation to improve assessment accuracy.\\'}], \\'required_controls\\': [\\'Detailed risk assessment and mitigation strategies\\', \\'Comprehensive OQ testing protocols\\', \\'Documented evidence of system validation\\', \\'Periodic review and revalidation procedures\\'], \\'certainty_score\\': 0.0}\\n        \\n        RISK ANALYSIS:\\n        {\\'identified_risks\\': [{\\'category\\': \\'Regulatory Compliance\\', \\'risk\\': \\'Potential gaps in meeting high compliance level requirements due to unknown GAMP category\\', \\'probability\\': \\'medium\\', \\'impact\\': \\'critical\\', \\'mitigation\\': \\'Conduct a detailed GAMP category assessment and align validation activities with regulatory expectations\\'}, {\\'category\\': \\'Data Integrity\\', \\'risk\\': \\'Risk of non-compliance with ALCOA+ principles during OQ testing\\', \\'probability\\': \\'high\\', \\'impact\\': \\'critical\\', \\'mitigation\\': \\'Implement robust data integrity controls and audit trails during OQ testing\\'}, {\\'category\\': \\'Technical Complexity\\', \\'risk\\': \\'Integration risks due to the complexity of GAMP Category 4 systems\\', \\'probability\\': \\'high\\', \\'impact\\': \\'high\\', \\'mitigation\\': \\'Perform thorough integration testing and ensure proper documentation of interfaces\\'}, {\\'category\\': \\'Validation Lifecycle\\', \\'risk\\': \\'Inadequate validation lifecycle management due to enhanced validation focus\\', \\'probability\\': \\'medium\\', \\'impact\\': \\'high\\', \\'mitigation\\': \\'Develop a comprehensive validation plan covering all lifecycle phases and ensure stakeholder alignment\\'}, {\\'category\\': \\'Change Control\\', \\'risk\\': \\'Insufficient configuration management leading to validation gaps\\', \\'probability\\': \\'medium\\', \\'impact\\': \\'high\\', \\'mitigation\\': \\'Establish a robust change control process and maintain a configuration management database\\'}], \\'risk_level\\': \\'high\\', \\'mitigation_strategies\\': [{\\'strategy\\': \\'Conduct a GAMP category assessment to clarify system classification\\', \\'priority\\': \\'critical\\', \\'timeline\\': \\'immediate\\'}, {\\'strategy\\': \\'Implement ALCOA+ compliant data integrity controls during OQ testing\\', \\'priority\\': \\'critical\\', \\'timeline\\': \\'immediate\\'}, {\\'strategy\\': \\'Perform integration testing and document interfaces thoroughly\\', \\'priority\\': \\'high\\', \\'timeline\\': \\'planned\\'}, {\\'strategy\\': \\'Develop a comprehensive validation plan covering all lifecycle phases\\', \\'priority\\': \\'high\\', \\'timeline\\': \\'planned\\'}, {\\'strategy\\': \\'Establish a robust change control process and maintain a configuration management database\\', \\'priority\\': \\'medium\\', \\'timeline\\': \\'future\\'}], \\'critical_concerns\\': [\\'Unknown GAMP category leading to potential regulatory compliance gaps\\', \\'Risk of non-compliance with ALCOA+ principles during OQ testing\\'], \\'clarity_score\\': 0.8}\\n        \\n        SYSTEM CONTEXT:\\n        - Specialty: GAMP Category 4\\n        - Compliance Level: high\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        - GAMP Category: unknown\\n        \\n        Generate up to 10 prioritized recommendations that address:\\n        1. Compliance gaps identified in the assessment\\n        2. Risk mitigation strategies\\n        3. Domain-specific best practices for GAMP Category 4\\n        4. Validation approach recommendations\\n        5. Implementation guidance\\n        \\n        Each recommendation must include:\\n        - Specific, actionable recommendation\\n        - Clear rationale tied to compliance/risk analysis\\n        - Priority level (high/medium/low)\\n        - Implementation effort estimate\\n        - Expected benefit category\\n        \\n        Respond with valid JSON in this exact format:\\n        [\\n            {\\n                \"category\": \"category_name\",\\n                \"priority\": \"critical/high/medium/low\",\\n                \"recommendation\": \"specific_actionable_recommendation\",\\n                \"rationale\": \"clear_justification\",\\n                \"implementation_effort\": \"high/medium/low\",\\n                \"expected_benefit\": \"benefit_category\"\\n            }\\n        ]\\n        ',)", "input.value": "\n        As a pharmaceutical validation expert specializing in GAMP Category 4, generate specific recommendations based on this analysis:\n        \n        COMPLIANCE ASSESSMENT:\n        {'level': 'high', 'applicable_standards': ['FDA 21 CFR Part 11', 'EU Annex 11', 'ICH Q7', 'GAMP 5'], 'compliance_gaps': [{'gap': 'Unknown GAMP Category', 'impact': 'high', 'recommendation': 'Determine the correct GAMP Category based on system complexity and intended use.'}, {'gap': 'Confidence Score of 0.0 indicates insufficient data for assessment', 'impact': 'high', 'recommendation': 'Gather additional system details and validation documentation to improve assessment accuracy.'}], 'required_controls': ['Detailed risk assessment and mitigation strategies', 'Comprehensive OQ testing protocols', 'Documented evidence of system validation', 'Periodic review and revalidation procedures'], 'certainty_score': 0.0}\n        \n        RISK ANALYSIS:\n        {'identified_risks': [{'category': 'Regulatory Compliance', 'risk': 'Potential gaps in meeting high compliance level requirements due to unknown GAMP category', 'probability': 'medium', 'impact': 'critical', 'mitigation': 'Conduct a detailed GAMP category assessment and align validation activities with regulatory expectations'}, {'category': 'Data Integrity', 'risk': 'Risk of non-compliance with ALCOA+ principles during OQ testing', 'probability': 'high', 'impact': 'critical', 'mitigation': 'Implement robust data integrity controls and audit trails during OQ testing'}, {'category': 'Technical Complexity', 'risk': 'Integration risks due to the complexity of GAMP Category 4 systems', 'probability': 'high', 'impact': 'high', 'mitigation': 'Perform thorough integration testing and ensure proper documentation of interfaces'}, {'category': 'Validation Lifecycle', 'risk': 'Inadequate validation lifecycle management due to enhanced validation focus', 'probability': 'medium', 'impact': 'high', 'mitigation': 'Develop a comprehensive validation plan covering all lifecycle phases and ensure stakeholder alignment'}, {'category': 'Change Control', 'risk': 'Insufficient configuration management leading to validation gaps', 'probability': 'medium', 'impact': 'high', 'mitigation': 'Establish a robust change control process and maintain a configuration management database'}], 'risk_level': 'high', 'mitigation_strategies': [{'strategy': 'Conduct a GAMP category assessment to clarify system classification', 'priority': 'critical', 'timeline': 'immediate'}, {'strategy': 'Implement ALCOA+ compliant data integrity controls during OQ testing', 'priority': 'critical', 'timeline': 'immediate'}, {'strategy': 'Perform integration testing and document interfaces thoroughly', 'priority': 'high', 'timeline': 'planned'}, {'strategy': 'Develop a comprehensive validation plan covering all lifecycle phases', 'priority': 'high', 'timeline': 'planned'}, {'strategy': 'Establish a robust change control process and maintain a configuration management database', 'priority': 'medium', 'timeline': 'future'}], 'critical_concerns': ['Unknown GAMP category leading to potential regulatory compliance gaps', 'Risk of non-compliance with ALCOA+ principles during OQ testing'], 'clarity_score': 0.8}\n        \n        SYSTEM CONTEXT:\n        - Specialty: GAMP Category 4\n        - Compliance Level: high\n        - Test Focus: OQ testing for pharmaceutical compliance\n        - GAMP Category: unknown\n        \n        Generate up to 10 prioritized recommendations that address:\n        1. Compliance gaps identified in the assessment\n        2. Risk mitigation strategies\n        3. Domain-specific best practices for GAMP Category 4\n        4. Validation approach recommendations\n        5. Implementation guidance\n        \n        Each recommendation must include:\n        - Specific, actionable recommendation\n        - Clear rationale tied to compliance/risk analysis\n        - Priority level (high/medium/low)\n        - Implementation effort estimate\n        - Expected benefit category\n        \n        Respond with valid JSON in this exact format:\n        [\n            {\n                \"category\": \"category_name\",\n                \"priority\": \"critical/high/medium/low\",\n                \"recommendation\": \"specific_actionable_recommendation\",\n                \"rationale\": \"clear_justification\",\n                \"implementation_effort\": \"high/medium/low\",\n                \"expected_benefit\": \"benefit_category\"\n            }\n        ]\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "```json\n[\n    {\n        \"category\": \"Compliance\",\n        \"priority\": \"critical\",\n        \"recommendation\": \"Conduct a detailed GAMP category assessment to determine the correct classification for the system.\",\n        \"rationale\": \"Unknown GAMP category poses a high risk of regulatory non-compliance and validation misalignment.\",\n        \"implementation_effort\": \"medium\",\n        \"expected_benefit\": \"Regulatory Compliance\"\n    },\n    {\n        \"category\": \"Data Integrity\",\n        \"priority\": \"critical\",\n        \"recommendation\": \"Implement ALCOA+ compliant data integrity controls during OQ testing.\",\n        \"rationale\": \"High risk of non-compliance with ALCOA+ principles during OQ testing could compromise data integrity.\",\n        \"implementation_effort\": \"high\",\n        \"expected_benefit\": \"Data Integrity\"\n    },\n    {\n        \"category\": \"Validation Lifecycle\",\n        \"priority\": \"high\",\n        \"recommendation\": \"Develop a comprehensive validation plan covering all lifecycle phases, including risk assessment, testing, and revalidation.\",\n        \"rationale\": \"Inadequate validation lifecycle management increases the risk of validation gaps and regulatory scrutiny.\",\n        \"implementation_effort\": \"high\",\n        \"expected_benefit\": \"Validation Effectiveness\"\n    },\n    {\n        \"category\": \"Technical Complexity\",\n        \"priority\": \"high\",\n        \"recommendation\": \"Perform thorough integration testing and document interfaces thoroughly to mitigate integration risks.\",\n        \"rationale\": \"High technical complexity of GAMP Category 4 systems increases the risk of integration failures.\",\n        \"implementation_effort\": \"high\",\n        \"expected_benefit\": \"System Reliability\"\n    },\n    {\n        \"category\": \"Change Control\",\n        \"priority\": \"medium\",\n        \"recommendation\": \"Establish a robust change control process and maintain a configuration management database.\",\n        \"rationale\": \"Insufficient configuration management can lead to validation gaps and system inconsistencies.\",\n        \"implementation_effort\": \"medium\",\n        \"expected_benefit\": \"Change Management\"\n    },\n    {\n        \"category\": \"Compliance\",\n        \"priority\": \"high\",\n        \"recommendation\": \"Gather additional system details and validation documentation to improve assessment accuracy.\",\n        \"rationale\": \"Confidence Score of 0.0 indicates insufficient data for accurate compliance assessment.\",\n        \"implementation_effort\": \"medium\",\n        \"expected_benefit\": \"Assessment Accuracy\"\n    },\n    {\n        \"category\": \"Risk Mitigation\",\n        \"priority\": \"high\",\n        \"recommendation\": \"Conduct a detailed risk assessment and implement mitigation strategies aligned with regulatory expectations.\",\n        \"rationale\": \"High-risk level requires proactive risk management to ensure compliance and system reliability.\",\n        \"implementation_effort\": \"high\",\n        \"expected_benefit\": \"Risk Reduction\"\n    },\n    {\n        \"category\": \"Validation Approach\",\n        \"priority\": \"high\",\n        \"recommendation\": \"Ensure comprehensive OQ testing protocols are in place and executed rigorously.\",\n        \"rationale\": \"OQ testing is critical for demonstrating system functionality and compliance with pharmaceutical standards.\",\n        \"implementation_effort\": \"high\",\n        \"expected_benefit\": \"Testing Effectiveness\"\n    },\n    {\n        \"category\": \"Best Practices\",\n        \"priority\": \"medium\",\n        \"recommendation\": \"Document all validation activities and maintain evidence of system validation for audit readiness.\",\n        \"rationale\": \"Documented evidence is essential for demonstrating compliance during regulatory inspections.\",\n        \"implementation_effort\": \"medium\",\n        \"expected_benefit\": \"Audit Readiness\"\n    },\n    {\n        \"category\": \"Implementation Guidance\",\n        \"priority\": \"medium\",\n        \"recommendation\": \"Establish periodic review and revalidation procedures to ensure ongoing compliance.\",\n        \"rationale\": \"Periodic reviews are necessary to address system changes and maintain validation status over time.\",\n        \"implementation_effort\": \"medium\",\n        \"expected_benefit\": \"Sustained Compliance\"\n    }\n]\n```", "llm.token_count.prompt": 1120, "llm.token_count.completion": 1054, "llm.token_count.total": 2174, "llm.latency_ms": 9454.212427139282}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:07.472069", "span_type": "llm", "prompt_tokens": 1120, "completion_tokens": 1054, "model": "deepseek/deepseek-chat"}
{"span_id": "53ebe51eb6b4d726", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "9ba89121294d6f65", "name": "sme.generate_recommendations", "kind": "INTERNAL", "start_time": 1755775078017063800, "end_time": 1755775087473465200, "duration_ns": 9456401400, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:07.473488"}
{"span_id": "b9747fc0be275c74", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "3b9c2437feebcddb", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775087474058100, "end_time": 1755775095165253400, "duration_ns": 7691195300, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('\\n        As a pharmaceutical validation expert specializing in GAMP Category 4, provide specific validation guidance based on:\\n        \\n        CONTEXT:\\n        - Specialty: GAMP Category 4\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        - Compliance Level: high\\n        - GAMP Category: unknown\\n        - Validation Focus Areas: enhanced\\n        \\n        RECOMMENDATIONS TO IMPLEMENT:\\n        [{\\'category\\': \\'Compliance\\', \\'priority\\': \\'critical\\', \\'recommendation\\': \\'Conduct a detailed GAMP category assessment to determine the correct classification for the system.\\', \\'rationale\\': \\'Unknown GAMP category poses a high risk of regulatory non-compliance and validation misalignment.\\', \\'implementation_effort\\': \\'medium\\', \\'expected_benefit\\': \\'Regulatory Compliance\\'}, {\\'category\\': \\'Data Integrity\\', \\'priority\\': \\'critical\\', \\'recommendation\\': \\'Implement ALCOA+ compliant data integrity controls during OQ testing.\\', \\'rationale\\': \\'High risk of non-compliance with ALCOA+ principles during OQ testing could compromise data integrity.\\', \\'implementation_effort\\': \\'high\\', \\'expected_benefit\\': \\'Data Integrity\\'}, {\\'category\\': \\'Validation Lifecycle\\', \\'priority\\': \\'high\\', \\'recommendation\\': \\'Develop a comprehensive validation plan covering all lifecycle phases, including risk assessment, testing, and revalidation.\\', \\'rationale\\': \\'Inadequate validation lifecycle management increases the risk of validation gaps and regulatory scrutiny.\\', \\'implementation_effort\\': \\'high\\', \\'expected_benefit\\': \\'Validation Effectiveness\\'}, {\\'category\\': \\'Technical Complexity\\', \\'priority\\': \\'high\\', \\'recommendation\\': \\'Perform thorough integration testing and document interfaces thoroughly to mitigate integration risks.\\', \\'rationale\\': \\'High technical complexity of GAMP Category 4 systems increases the risk of integration failures.\\', \\'implementation_effort\\': \\'high\\', \\'expected_benefit\\': \\'System Reliability\\'}, {\\'category\\': \\'Change Control\\', \\'priority\\': \\'medium\\', \\'recommendation\\': \\'Establish a robust change control process and maintain a configuration management database.\\', \\'rationale\\': \\'Insufficient configuration management can lead to validation gaps and system inconsistencies.\\', \\'implementation_effort\\': \\'medium\\', \\'expected_benefit\\': \\'Change Management\\'}, {\\'category\\': \\'Compliance\\', \\'priority\\': \\'high\\', \\'recommendation\\': \\'Gather additional system details and validation documentation to improve assessment accuracy.\\', \\'rationale\\': \\'Confidence Score of 0.0 indicates insufficient data for accurate compliance assessment.\\', \\'implementation_effort\\': \\'medium\\', \\'expected_benefit\\': \\'Assessment Accuracy\\'}, {\\'category\\': \\'Risk Mitigation\\', \\'priority\\': \\'high\\', \\'recommendation\\': \\'Conduct a detailed risk assessment and implement mitigation strategies aligned with regulatory expectations.\\', \\'rationale\\': \\'High-risk level requires proactive risk management to ensure compliance and system reliability.\\', \\'implementation_effort\\': \\'high\\', \\'expected_benefit\\': \\'Risk Reduction\\'}, {\\'category\\': \\'Validation Approach\\', \\'priority\\': \\'high\\', \\'recommendation\\': \\'Ensure comprehensive OQ testing protocols are in place and executed rigorously.\\', \\'rationale\\': \\'OQ testing is critical for demonstrating system functionality and compliance with pharmaceutical standards.\\', \\'implementation_effort\\': \\'high\\', \\'expected_benefit\\': \\'Testing Effectiveness\\'}, {\\'category\\': \\'Best Practices\\', \\'priority\\': \\'medium\\', \\'recommendation\\': \\'Document all validation activities and maintain evidence of system validation for audit readiness.\\', \\'rationale\\': \\'Documented evidence is essential for demonstrating compliance during regulatory inspections.\\', \\'implementation_effort\\': \\'medium\\', \\'expected_benefit\\': \\'Audit Readiness\\'}, {\\'category\\': \\'Implementation Guidance\\', \\'priority\\': \\'medium\\', \\'recommendation\\': \\'Establish periodic review and revalidation procedures to ensure ongoing compliance.\\', \\'rationale\\': \\'Periodic reviews are necessary to address system changes and maintain validation status over time.\\', \\'implementation_effort\\': \\'medium\\', \\'expected_benefit\\': \\'Sustained Compliance\\'}]\\n        \\n        Provide specific, actionable validation guidance covering:\\n        1. Test strategy approach tailored to the test focus\\n        2. Compliance validation procedures for the compliance level\\n        3. Risk management guidance based on recommendations\\n        4. Domain-specific validation approaches\\n        5. Quality assurance considerations\\n        \\n        Each guidance item should include:\\n        - Area of focus\\n        - Specific guidance instructions\\n        - Key considerations/checkpoints\\n        - Clear success criteria\\n        \\n        Respond with valid JSON in this exact format:\\n        [\\n            {\\n                \"area\": \"area_name\",\\n                \"guidance\": \"specific_guidance_instructions\",\\n                \"key_considerations\": [\"consideration1\", \"consideration2\"],\\n                \"success_criteria\": \"clear_success_criteria\"\\n            }\\n        ]\\n        ',)", "input.value": "\n        As a pharmaceutical validation expert specializing in GAMP Category 4, provide specific validation guidance based on:\n        \n        CONTEXT:\n        - Specialty: GAMP Category 4\n        - Test Focus: OQ testing for pharmaceutical compliance\n        - Compliance Level: high\n        - GAMP Category: unknown\n        - Validation Focus Areas: enhanced\n        \n        RECOMMENDATIONS TO IMPLEMENT:\n        [{'category': 'Compliance', 'priority': 'critical', 'recommendation': 'Conduct a detailed GAMP category assessment to determine the correct classification for the system.', 'rationale': 'Unknown GAMP category poses a high risk of regulatory non-compliance and validation misalignment.', 'implementation_effort': 'medium', 'expected_benefit': 'Regulatory Compliance'}, {'category': 'Data Integrity', 'priority': 'critical', 'recommendation': 'Implement ALCOA+ compliant data integrity controls during OQ testing.', 'rationale': 'High risk of non-compliance with ALCOA+ principles during OQ testing could compromise data integrity.', 'implementation_effort': 'high', 'expected_benefit': 'Data Integrity'}, {'category': 'Validation Lifecycle', 'priority': 'high', 'recommendation': 'Develop a comprehensive validation plan covering all lifecycle phases, including risk assessment, testing, and revalidation.', 'rationale': 'Inadequate validation lifecycle management increases the risk of validation gaps and regulatory scrutiny.', 'implementation_effort': 'high', 'expected_benefit': 'Validation Effectiveness'}, {'category': 'Technical Complexity', 'priority': 'high', 'recommendation': 'Perform thorough integration testing and document interfaces thoroughly to mitigate integration risks.', 'rationale': 'High technical complexity of GAMP Category 4 systems increases the risk of integration failures.', 'implementation_effort': 'high', 'expected_benefit': 'System Reliability'}, {'category': 'Change Control', 'priority': 'medium', 'recommendation': 'Establish a robust change control process and maintain a configuration management database.', 'rationale': 'Insufficient configuration management can lead to validation gaps and system inconsistencies.', 'implementation_effort': 'medium', 'expected_benefit': 'Change Management'}, {'category': 'Compliance', 'priority': 'high', 'recommendation': 'Gather additional system details and validation documentation to improve assessment accuracy.', 'rationale': 'Confidence Score of 0.0 indicates insufficient data for accurate compliance assessment.', 'implementation_effort': 'medium', 'expected_benefit': 'Assessment Accuracy'}, {'category': 'Risk Mitigation', 'priority': 'high', 'recommendation': 'Conduct a detailed risk assessment and implement mitigation strategies aligned with regulatory expectations.', 'rationale': 'High-risk level requires proactive risk management to ensure compliance and system reliability.', 'implementation_effort': 'high', 'expected_benefit': 'Risk Reduction'}, {'category': 'Validation Approach', 'priority': 'high', 'recommendation': 'Ensure comprehensive OQ testing protocols are in place and executed rigorously.', 'rationale': 'OQ testing is critical for demonstrating system functionality and compliance with pharmaceutical standards.', 'implementation_effort': 'high', 'expected_benefit': 'Testing Effectiveness'}, {'category': 'Best Practices', 'priority': 'medium', 'recommendation': 'Document all validation activities and maintain evidence of system validation for audit readiness.', 'rationale': 'Documented evidence is essential for demonstrating compliance during regulatory inspections.', 'implementation_effort': 'medium', 'expected_benefit': 'Audit Readiness'}, {'category': 'Implementation Guidance', 'priority': 'medium', 'recommendation': 'Establish periodic review and revalidation procedures to ensure ongoing compliance.', 'rationale': 'Periodic reviews are necessary to address system changes and maintain validation status over time.', 'implementation_effort': 'medium', 'expected_benefit': 'Sustained Compliance'}]\n        \n        Provide specific, actionable validation guidance covering:\n        1. Test strategy approach tailored to the test focus\n        2. Compliance validation procedures for the compliance level\n        3. Risk management guidance based on recommendations\n        4. Domain-specific validation approaches\n        5. Quality assurance considerations\n        \n        Each guidance item should include:\n        - Area of focus\n        - Specific guidance instructions\n        - Key considerations/checkpoints\n        - Clear success criteria\n        \n        Respond with valid JSON in this exact format:\n        [\n            {\n                \"area\": \"area_name\",\n                \"guidance\": \"specific_guidance_instructions\",\n                \"key_considerations\": [\"consideration1\", \"consideration2\"],\n                \"success_criteria\": \"clear_success_criteria\"\n            }\n        ]\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "```json\n[\n    {\n        \"area\": \"Test Strategy Approach\",\n        \"guidance\": \"Develop a detailed OQ test strategy focusing on functional and operational requirements. Include test cases for system functionality, performance, and boundary conditions. Ensure traceability to user requirements and design specifications.\",\n        \"key_considerations\": [\"Ensure test cases cover all critical functionalities\", \"Verify traceability to user requirements\", \"Include boundary and stress testing\"],\n        \"success_criteria\": \"All OQ test cases executed successfully with documented evidence of compliance.\"\n    },\n    {\n        \"area\": \"Compliance Validation Procedures\",\n        \"guidance\": \"Conduct a GAMP category assessment to classify the system accurately. Implement ALCOA+ compliant data integrity controls during OQ testing. Gather and review all system details and validation documentation to ensure alignment with regulatory standards.\",\n        \"key_considerations\": [\"Accurate GAMP category classification\", \"ALCOA+ compliance in data handling\", \"Complete and accurate validation documentation\"],\n        \"success_criteria\": \"System classified correctly, ALCOA+ compliance verified, and all validation documentation reviewed and approved.\"\n    },\n    {\n        \"area\": \"Risk Management Guidance\",\n        \"guidance\": \"Perform a detailed risk assessment focusing on integration risks, data integrity, and regulatory compliance. Implement mitigation strategies such as thorough integration testing, robust change control processes, and periodic reviews.\",\n        \"key_considerations\": [\"Identify and prioritize high-risk areas\", \"Implement effective mitigation strategies\", \"Document risk assessment and mitigation actions\"],\n        \"success_criteria\": \"Risk assessment completed, mitigation strategies implemented, and risks reduced to acceptable levels.\"\n    },\n    {\n        \"area\": \"Domain-Specific Validation Approaches\",\n        \"guidance\": \"Adopt a lifecycle approach to validation, covering risk assessment, testing, and revalidation. Ensure comprehensive OQ testing protocols are in place and executed rigorously. Document all validation activities and maintain evidence for audit readiness.\",\n        \"key_considerations\": [\"Lifecycle validation approach\", \"Rigorous OQ testing execution\", \"Documentation and audit readiness\"],\n        \"success_criteria\": \"Validation lifecycle managed effectively, OQ testing completed successfully, and audit-ready documentation maintained.\"\n    },\n    {\n        \"area\": \"Quality Assurance Considerations\",\n        \"guidance\": \"Establish a robust quality assurance framework to oversee validation activities. Ensure periodic review and revalidation procedures are in place. Maintain a configuration management database to track changes and ensure system consistency.\",\n        \"key_considerations\": [\"Quality oversight of validation activities\", \"Periodic review and revalidation\", \"Configuration management\"],\n        \"success_criteria\": \"Quality assurance framework established, periodic reviews conducted, and configuration management database maintained.\"\n    }\n]\n```", "llm.token_count.prompt": 1236, "llm.token_count.completion": 780, "llm.token_count.total": 2016, "llm.latency_ms": 7691.005229949951}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:15.165378", "span_type": "llm", "prompt_tokens": 1236, "completion_tokens": 780, "model": "deepseek/deepseek-chat"}
{"span_id": "3b9c2437feebcddb", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "9ba89121294d6f65", "name": "sme.validation_guidance", "kind": "INTERNAL", "start_time": 1755775087473787400, "end_time": 1755775095166693900, "duration_ns": 7692906500, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:15.166744"}
{"span_id": "b596380a68241c33", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "f67dfda248e4d071", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775095167263900, "end_time": 1755775099186432800, "duration_ns": 4019168900, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('\\n        As a pharmaceutical validation expert specializing in GAMP Category 4, provide domain-specific insights for a validation project with these characteristics:\\n        \\n        - Specialty: GAMP Category 4\\n        - Compliance Level: high\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        - Domain Knowledge Areas: \\n        - GAMP Category: unknown\\n        \\n        Provide comprehensive domain insights including:\\n        1. Current industry trends affecting GAMP Category 4\\n        2. Best practices specific to this specialty and compliance level\\n        3. Common pitfalls to avoid in GAMP Category 4 projects\\n        4. Key expertise areas that are critical for success\\n        5. Emerging challenges and opportunities\\n        \\n        Focus on practical, actionable insights that can improve validation outcomes.\\n        \\n        Respond with valid JSON in this exact format:\\n        {\\n            \"specialty_focus\": \"specialty_name\",\\n            \"key_expertise_areas\": [\"area1\", \"area2\"],\\n            \"industry_trends\": [\"trend1\", \"trend2\"],\\n            \"best_practices\": [\"practice1\", \"practice2\"],\\n            \"common_pitfalls\": [\"pitfall1\", \"pitfall2\"],\\n            \"emerging_challenges\": [\"challenge1\", \"challenge2\"],\\n            \"opportunities\": [\"opportunity1\", \"opportunity2\"]\\n        }\\n        ',)", "input.value": "\n        As a pharmaceutical validation expert specializing in GAMP Category 4, provide domain-specific insights for a validation project with these characteristics:\n        \n        - Specialty: GAMP Category 4\n        - Compliance Level: high\n        - Test Focus: OQ testing for pharmaceutical compliance\n        - Domain Knowledge Areas: \n        - GAMP Category: unknown\n        \n        Provide comprehensive domain insights including:\n        1. Current industry trends affecting GAMP Category 4\n        2. Best practices specific to this specialty and compliance level\n        3. Common pitfalls to avoid in GAMP Category 4 projects\n        4. Key expertise areas that are critical for success\n        5. Emerging challenges and opportunities\n        \n        Focus on practical, actionable insights that can improve validation outcomes.\n        \n        Respond with valid JSON in this exact format:\n        {\n            \"specialty_focus\": \"specialty_name\",\n            \"key_expertise_areas\": [\"area1\", \"area2\"],\n            \"industry_trends\": [\"trend1\", \"trend2\"],\n            \"best_practices\": [\"practice1\", \"practice2\"],\n            \"common_pitfalls\": [\"pitfall1\", \"pitfall2\"],\n            \"emerging_challenges\": [\"challenge1\", \"challenge2\"],\n            \"opportunities\": [\"opportunity1\", \"opportunity2\"]\n        }\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"specialty_focus\": \"GAMP Category 4\",\n    \"key_expertise_areas\": [\"system lifecycle management\", \"risk-based validation\", \"regulatory compliance\", \"technical documentation\", \"OQ/PQ testing\"],\n    \"industry_trends\": [\"increased adoption of digital validation tools\", \"focus on data integrity and ALCOA+ principles\", \"integration of AI and machine learning in validation processes\", \"emphasis on continuous validation and monitoring\"],\n    \"best_practices\": [\"implement risk-based validation strategies\", \"ensure thorough documentation and traceability\", \"leverage automation for repetitive testing tasks\", \"conduct regular training on GAMP guidelines\", \"collaborate closely with vendors for system-specific requirements\"],\n    \"common_pitfalls\": [\"inadequate risk assessment leading to gaps in validation\", \"poor documentation practices causing audit failures\", \"over-reliance on vendor-provided testing scripts\", \"insufficient training on GAMP Category 4 specifics\", \"failure to align validation with regulatory updates\"],\n    \"emerging_challenges\": [\"managing validation for increasingly complex systems\", \"ensuring compliance with evolving global regulations\", \"integrating legacy systems with modern validation practices\", \"addressing cybersecurity risks in validation processes\"],\n    \"opportunities\": [\"leveraging advanced analytics for predictive validation\", \"adopting cloud-based validation platforms for scalability\", \"enhancing collaboration between validation and IT teams\", \"exploring AI-driven validation tools for efficiency\", \"positioning validation as a strategic enabler of digital transformation\"]\n}", "llm.token_count.prompt": 334, "llm.token_count.completion": 405, "llm.token_count.total": 739, "llm.latency_ms": 4018.9805030822754}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:19.186523", "span_type": "llm", "prompt_tokens": 334, "completion_tokens": 405, "model": "deepseek/deepseek-chat"}
{"span_id": "f67dfda248e4d071", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "9ba89121294d6f65", "name": "sme.domain_insights", "kind": "INTERNAL", "start_time": 1755775095167045300, "end_time": 1755775099187493700, "duration_ns": 4020448400, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:19.187518"}
{"span_id": "d204773388f9a5ca", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "094230086537b2b9", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775099188526300, "end_time": 1755775107760565800, "duration_ns": 8572039500, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('\\n        As a pharmaceutical regulatory expert specializing in GAMP Category 4, assess the regulatory considerations for a validation project with these characteristics:\\n        \\n        - Specialty: GAMP Category 4\\n        - Compliance Level: high\\n        - GAMP Category: unknown\\n        - Validation Focus: enhanced\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        \\n        Assess regulatory considerations including:\\n        1. GAMP-5 category-specific requirements\\n        2. 21 CFR Part 11 electronic records compliance\\n        3. FDA Data Integrity Guidance (ALCOA+ principles)\\n        4. ICH guidelines applicable to the specialty\\n        5. EU GMP Annex 11 requirements\\n        6. Any specialty-specific regulatory requirements\\n        \\n        For each consideration, provide:\\n        - Specific regulation/guideline\\n        - Key consideration or requirement\\n        - Impact level (low/medium/high/critical)\\n        - Required actions\\n        - Implementation timeline phase\\n        \\n        Respond with valid JSON in this exact format:\\n        [\\n            {\\n                \"regulation\": \"regulation_name\",\\n                \"consideration\": \"specific_consideration_or_requirement\",\\n                \"impact\": \"low/medium/high/critical\",\\n                \"action_required\": \"specific_action_needed\",\\n                \"timeline\": \"design_phase/implementation_phase/validation_phase/ongoing\"\\n            }\\n        ]\\n        ',)", "input.value": "\n        As a pharmaceutical regulatory expert specializing in GAMP Category 4, assess the regulatory considerations for a validation project with these characteristics:\n        \n        - Specialty: GAMP Category 4\n        - Compliance Level: high\n        - GAMP Category: unknown\n        - Validation Focus: enhanced\n        - Test Focus: OQ testing for pharmaceutical compliance\n        \n        Assess regulatory considerations including:\n        1. GAMP-5 category-specific requirements\n        2. 21 CFR Part 11 electronic records compliance\n        3. FDA Data Integrity Guidance (ALCOA+ principles)\n        4. ICH guidelines applicable to the specialty\n        5. EU GMP Annex 11 requirements\n        6. Any specialty-specific regulatory requirements\n        \n        For each consideration, provide:\n        - Specific regulation/guideline\n        - Key consideration or requirement\n        - Impact level (low/medium/high/critical)\n        - Required actions\n        - Implementation timeline phase\n        \n        Respond with valid JSON in this exact format:\n        [\n            {\n                \"regulation\": \"regulation_name\",\n                \"consideration\": \"specific_consideration_or_requirement\",\n                \"impact\": \"low/medium/high/critical\",\n                \"action_required\": \"specific_action_needed\",\n                \"timeline\": \"design_phase/implementation_phase/validation_phase/ongoing\"\n            }\n        ]\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "```json\n[\n    {\n        \"regulation\": \"GAMP-5\",\n        \"consideration\": \"Category 4 systems require a risk-based approach to validation, focusing on critical functionality and ensuring compliance with pharmaceutical regulations.\",\n        \"impact\": \"high\",\n        \"action_required\": \"Conduct a risk assessment to identify critical functionalities and define validation scope.\",\n        \"timeline\": \"design_phase\"\n    },\n    {\n        \"regulation\": \"21 CFR Part 11\",\n        \"consideration\": \"Ensure electronic records and signatures are secure, reliable, and traceable, with appropriate controls for access and audit trails.\",\n        \"impact\": \"critical\",\n        \"action_required\": \"Implement electronic record controls, including audit trails, user access management, and data integrity checks.\",\n        \"timeline\": \"implementation_phase\"\n    },\n    {\n        \"regulation\": \"FDA Data Integrity Guidance (ALCOA+)\",\n        \"consideration\": \"Ensure data is Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available.\",\n        \"impact\": \"critical\",\n        \"action_required\": \"Establish data integrity controls and verify compliance with ALCOA+ principles during OQ testing.\",\n        \"timeline\": \"validation_phase\"\n    },\n    {\n        \"regulation\": \"ICH Q7\",\n        \"consideration\": \"Ensure compliance with Good Manufacturing Practice (GMP) for active pharmaceutical ingredients (APIs).\",\n        \"impact\": \"medium\",\n        \"action_required\": \"Review and align validation processes with ICH Q7 guidelines.\",\n        \"timeline\": \"design_phase\"\n    },\n    {\n        \"regulation\": \"EU GMP Annex 11\",\n        \"consideration\": \"Ensure computerized systems are validated, with appropriate risk management, data integrity, and change control processes.\",\n        \"impact\": \"high\",\n        \"action_required\": \"Implement Annex 11 requirements, including risk management, validation, and change control procedures.\",\n        \"timeline\": \"implementation_phase\"\n    },\n    {\n        \"regulation\": \"Specialty-specific requirements\",\n        \"consideration\": \"Identify and comply with any additional regulatory requirements specific to the pharmaceutical product or process.\",\n        \"impact\": \"medium\",\n        \"action_required\": \"Conduct a regulatory gap analysis to identify and address specialty-specific requirements.\",\n        \"timeline\": \"design_phase\"\n    }\n]\n```", "llm.token_count.prompt": 363, "llm.token_count.completion": 603, "llm.token_count.total": 966, "llm.latency_ms": 8571.8092918396}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:27.760665", "span_type": "llm", "prompt_tokens": 363, "completion_tokens": 603, "model": "deepseek/deepseek-chat"}
{"span_id": "094230086537b2b9", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "9ba89121294d6f65", "name": "sme.regulatory_considerations", "kind": "INTERNAL", "start_time": 1755775099187991600, "end_time": 1755775107761722300, "duration_ns": 8573730700, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:27.761748"}
{"span_id": "940b439ec810beda", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "d5ab5c0fbb6e4716", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775107762361800, "end_time": 1755775110198686400, "duration_ns": 2436324600, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "(\"\\n        As a pharmaceutical validation expert specializing in GAMP Category 4, formulate a comprehensive expert opinion based on the complete analysis conducted:\\n        \\n        SYSTEM CONTEXT:\\n        - Specialty: GAMP Category 4\\n        - Compliance Level: high\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        - GAMP Category: unknown\\n        \\n        ANALYSIS RESULTS:\\n        Risk Analysis: {'identified_risks': [{'category': 'Regulatory Compliance', 'risk': 'Potential gaps in meeting high compliance level requirements due to unknown GAMP category', 'probability': 'medium', 'impact': 'critical', 'mitigation': 'Conduct a detailed GAMP category assessment and align validation activities with regulatory expectations'}, {'category': 'Data Integrity', 'risk': 'Risk of non-compliance with ALCOA+ principles during OQ testing', 'probability': 'high', 'impact': 'critical', 'mitigation': 'Implement robust data integrity controls and audit trails during OQ testing'}, {'category': 'Technical Complexity', 'risk': 'Integration risks due to the complexity of GAMP Category 4 systems', 'probability': 'high', 'impact': 'high', 'mitigation': 'Perform thorough integration testing and ensure proper documentation of interfaces'}, {'category': 'Validation Lifecycle', 'risk': 'Inadequate validation lifecycle management due to enhanced validation focus', 'probability': 'medium', 'impact': 'high', 'mitigation': 'Develop a comprehensive validation plan covering all lifecycle phases and ensure stakeholder alignment'}, {'category': 'Change Control', 'risk': 'Insufficient configuration management leading to validation gaps', 'probability': 'medium', 'impact': 'high', 'mitigation': 'Establish a robust change control process and maintain a configuration management database'}], 'risk_level': 'high', 'mitigation_strategies': [{'strategy': 'Conduct a GAMP category assessment to clarify system classification', 'priority': 'critical', 'timeline': 'immediate'}, {'strategy': 'Implement ALCOA+ compliant data integrity controls during OQ testing', 'priority': 'critical', 'timeline': 'immediate'}, {'strategy': 'Perform integration testing and document interfaces thoroughly', 'priority': 'high', 'timeline': 'planned'}, {'strategy': 'Develop a comprehensive validation plan covering all lifecycle phases', 'priority': 'high', 'timeline': 'planned'}, {'strategy': 'Establish a robust change control process and maintain a configuration management database', 'priority': 'medium', 'timeline': 'future'}], 'critical_concerns': ['Unknown GAMP category leading to potential regulatory compliance gaps', 'Risk of non-compliance with ALCOA+ principles during OQ testing'], 'clarity_score': 0.8}\\n        \\n        Recommendations Generated: 10 recommendations\\n        High Priority Recommendations: 5\\n        \\n        Formulate a concise expert opinion that:\\n        1. Summarizes the overall validation approach recommended\\n        2. Highlights key risk considerations and mitigation strategies\\n        3. Provides guidance on implementation priorities\\n        4. Addresses compliance and regulatory considerations\\n        5. Offers professional judgment on success likelihood\\n        \\n        Write in a professional, authoritative tone appropriate for pharmaceutical validation documentation.\\n        Keep the opinion concise but comprehensive (2-4 sentences).\\n        \\n        Respond with just the expert opinion text, no JSON formatting needed.\\n        \",)", "input.value": "\n        As a pharmaceutical validation expert specializing in GAMP Category 4, formulate a comprehensive expert opinion based on the complete analysis conducted:\n        \n        SYSTEM CONTEXT:\n        - Specialty: GAMP Category 4\n        - Compliance Level: high\n        - Test Focus: OQ testing for pharmaceutical compliance\n        - GAMP Category: unknown\n        \n        ANALYSIS RESULTS:\n        Risk Analysis: {'identified_risks': [{'category': 'Regulatory Compliance', 'risk': 'Potential gaps in meeting high compliance level requirements due to unknown GAMP category', 'probability': 'medium', 'impact': 'critical', 'mitigation': 'Conduct a detailed GAMP category assessment and align validation activities with regulatory expectations'}, {'category': 'Data Integrity', 'risk': 'Risk of non-compliance with ALCOA+ principles during OQ testing', 'probability': 'high', 'impact': 'critical', 'mitigation': 'Implement robust data integrity controls and audit trails during OQ testing'}, {'category': 'Technical Complexity', 'risk': 'Integration risks due to the complexity of GAMP Category 4 systems', 'probability': 'high', 'impact': 'high', 'mitigation': 'Perform thorough integration testing and ensure proper documentation of interfaces'}, {'category': 'Validation Lifecycle', 'risk': 'Inadequate validation lifecycle management due to enhanced validation focus', 'probability': 'medium', 'impact': 'high', 'mitigation': 'Develop a comprehensive validation plan covering all lifecycle phases and ensure stakeholder alignment'}, {'category': 'Change Control', 'risk': 'Insufficient configuration management leading to validation gaps', 'probability': 'medium', 'impact': 'high', 'mitigation': 'Establish a robust change control process and maintain a configuration management database'}], 'risk_level': 'high', 'mitigation_strategies': [{'strategy': 'Conduct a GAMP category assessment to clarify system classification', 'priority': 'critical', 'timeline': 'immediate'}, {'strategy': 'Implement ALCOA+ compliant data integrity controls during OQ testing', 'priority': 'critical', 'timeline': 'immediate'}, {'strategy': 'Perform integration testing and document interfaces thoroughly', 'priority': 'high', 'timeline': 'planned'}, {'strategy': 'Develop a comprehensive validation plan covering all lifecycle phases', 'priority': 'high', 'timeline': 'planned'}, {'strategy': 'Establish a robust change control process and maintain a configuration management database', 'priority': 'medium', 'timeline': 'future'}], 'critical_concerns': ['Unknown GAMP category leading to potential regulatory compliance gaps', 'Risk of non-compliance with ALCOA+ principles during OQ testing'], 'clarity_score': 0.8}\n        \n        Recommendations Generated: 10 recommendations\n        High Priority Recommendations: 5\n        \n        Formulate a concise expert opinion that:\n        1. Summarizes the overall validation approach recommended\n        2. Highlights key risk considerations and mitigation strategies\n        3. Provides guidance on implementation priorities\n        4. Addresses compliance and regulatory considerations\n        5. Offers professional judgment on success likelihood\n        \n        Write in a professional, authoritative tone appropriate for pharmaceutical validation documentation.\n        Keep the opinion concise but comprehensive (2-4 sentences).\n        \n        Respond with just the expert opinion text, no JSON formatting needed.\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "Given the high compliance level and unknown GAMP category, the recommended validation approach emphasizes a thorough GAMP category assessment, robust ALCOA+ compliant data integrity controls, and comprehensive integration testing to mitigate critical risks. Immediate priorities include clarifying the GAMP classification and implementing stringent data integrity measures during OQ testing, while planned actions focus on lifecycle validation and change control processes. Success likelihood is high provided these strategies are executed diligently, ensuring alignment with regulatory expectations and minimizing compliance gaps.", "llm.token_count.prompt": 868, "llm.token_count.completion": 157, "llm.token_count.total": 1025, "llm.latency_ms": 2436.03777885437}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:30.198925", "span_type": "llm", "prompt_tokens": 868, "completion_tokens": 157, "model": "deepseek/deepseek-chat"}
{"span_id": "d5ab5c0fbb6e4716", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "9ba89121294d6f65", "name": "sme.expert_opinion", "kind": "INTERNAL", "start_time": 1755775107762051400, "end_time": 1755775110200120100, "duration_ns": 2438068700, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:30.200255"}
{"span_id": "9ba89121294d6f65", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": "90d4f754fe3d9278", "name": "sme.execute", "kind": "INTERNAL", "start_time": 1755775064776310600, "end_time": 1755775110200990200, "duration_ns": 45424679600, "status": {"status_code": "UNSET", "description": null}, "attributes": {"sme.request_id": "2c650716-d127-4d3f-b901-d13b75342d93", "sme.specialty": "GAMP Category 4", "sme.compliance_level": "high", "sme.compliance_status": "unknown", "sme.risk_level": "high", "sme.recommendations_count": 10, "sme.confidence_score": 0.5800000000000001, "sme.final_confidence": 0.5800000000000001, "sme.recommendations_final": 10}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:30.201038"}
{"span_id": "90d4f754fe3d9278", "trace_id": "cfa08de446fefe4f90aa07f185533028", "parent_id": null, "name": "sme_agent.process_request", "kind": "INTERNAL", "start_time": 1755775064776131200, "end_time": 1755775110201713100, "duration_ns": 45425581900, "status": {"status_code": "UNSET", "description": null}, "attributes": {"agent.method": "process_request", "agent.module": "src.agents.parallel.sme_agent", "agent.type": "sme_agent", "operation": "process_request", "agent.class": "SMEAgent", "request.correlation_id": "2c650716-d127-4d3f-b901-d13b75342d93", "request.specialty": "GAMP Category 4", "request.compliance_level": "high", "request.test_focus": "OQ testing for pharmaceutical compliance", "request.risk_factors": "{}", "request.timeout_seconds": 360, "compliance.gamp5.sme": true, "compliance.pharmaceutical": true, "sme.specialty": "GAMP Category 4", "result.recommendations_count": 10, "result.confidence_score": 0.5800000000000001, "result.risk_level": "high", "result.validation_points_count": 0, "result.processing_time_seconds": 45.425172, "result.success": true}, "events": [{"name": "sme_analysis_start", "timestamp": 1755775064776270000, "attributes": {"specialty": "GAMP Category 4", "compliance_level": "high", "test_focus": "OQ testing for pharmaceutical compliance"}}, {"name": "sme_analysis_complete", "timestamp": 1755775110201394900, "attributes": {"recommendations_count": 10, "confidence_score": 0.5800000000000001, "risk_level": "high", "processing_time": 45.425172}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:30.201766"}
{"span_id": "a119746ba6c79c59", "trace_id": "9157581022bc812e3d354b4e054d8c20", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775110217476200, "end_time": 1755775118499336100, "duration_ns": 8281859900, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 1 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-018.md\\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\\n**GAMP Category**: Ambiguous\\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\\n**Domain**: Analytical Chemistry (QC Lab)\\n**Complexity Level**: Medium\\n\\n## 1. Introduction\\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor\\'s built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier\\'s configuration tools for lab-specific routing.\\n\\n## 2. Functional Requirements\\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\\n- URS-018-003: The module shall provide vendor\\'s standard reporting engine with configured templates for batch results.\\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\\n\\n## 3. Regulatory Requirements\\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\\n- URS-018-015: Report templates shall be controlled artifacts under document control.\\n- URS-018-016: Access controls shall follow least privilege with periodic review.\\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\\n\\n## 4. Performance Requirements\\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\\n\\n## 5. Integration Requirements\\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\\n- URS-018-025: Pull instrument availability and calibration status from asset system.\\n- URS-018-026: Push finalized batch reports to the controlled document repository.\\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\\n\\n\\n\\n\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-001 through OQ-002\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-001, OQ-002, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-001\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 1 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-018.md\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\n**GAMP Category**: Ambiguous\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\n**Domain**: Analytical Chemistry (QC Lab)\n**Complexity Level**: Medium\n\n## 1. Introduction\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor's built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier's configuration tools for lab-specific routing.\n\n## 2. Functional Requirements\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\n- URS-018-003: The module shall provide vendor's standard reporting engine with configured templates for batch results.\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\n\n## 3. Regulatory Requirements\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\n- URS-018-015: Report templates shall be controlled artifacts under document control.\n- URS-018-016: Access controls shall follow least privilege with periodic review.\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\n\n## 4. Performance Requirements\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\n\n## 5. Integration Requirements\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\n- URS-018-025: Pull instrument availability and calibration status from asset system.\n- URS-018-026: Push finalized batch reports to the controlled document repository.\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\n\n\n\n\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-001 through OQ-002\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-001, OQ-002, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-001\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-001\",\n            \"test_name\": \"Sample Run Schedule Creation and Method Locking\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that users can create sample run schedules with priority, instrument, and method selections, and that the system enforces method-version locking for scheduled runs.\",\n            \"prerequisites\": [\"Access to the Chromatography Sample Scheduling Module\", \"Configured instruments and methods\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system with appropriate credentials.\",\n                    \"expected_result\": \"User successfully logs in and gains access to the scheduling module.\",\n                    \"data_to_capture\": [\"Login timestamp\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new sample run schedule with priority, instrument, and method selections.\",\n                    \"expected_result\": \"Schedule is created and displayed in the system.\",\n                    \"data_to_capture\": [\"Schedule details\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Attempt to modify the method version for the scheduled run.\",\n                    \"expected_result\": \"System prevents modification and enforces method-version locking.\",\n                    \"data_to_capture\": [\"Error message\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Schedule is created successfully\", \"Method-version locking is enforced\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Audit trail entries for schedule changes\"],\n            \"urs_requirements\": [\"URS-018-001\", \"URS-018-002\"],\n            \"related_tests\": [\"OQ-002\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Chromatography scheduling\"]\n        },\n        {\n            \"test_id\": \"OQ-002\",\n            \"test_name\": \"Instrument Routing and Availability Rules\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that the system routes samples to instruments based on configured availability rules and supports pause/resume and re-queue of failed runs with reason capture.\",\n            \"prerequisites\": [\"Access to the Chromatography Sample Scheduling Module\", \"Configured availability rules\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system with appropriate credentials.\",\n                    \"expected_result\": \"User successfully logs in and gains access to the scheduling module.\",\n                    \"data_to_capture\": [\"Login timestamp\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a sample run schedule and assign it to an instrument based on availability rules.\",\n                    \"expected_result\": \"Schedule is assigned to the correct instrument based on availability.\",\n                    \"data_to_capture\": [\"Schedule details\", \"Instrument assignment\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Simulate a failed run and attempt to pause/resume and re-queue the run.\",\n                    \"expected_result\": \"System allows pause/resume and re-queue with reason capture.\",\n                    \"data_to_capture\": [\"Reason for failure\", \"Re-queue details\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Samples are routed correctly based on availability rules\", \"Failed runs can be paused/resumed and re-queued\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Audit trail entries for run changes\"],\n            \"urs_requirements\": [\"URS-018-004\", \"URS-018-005\"],\n            \"related_tests\": [\"OQ-001\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Chromatography scheduling\"]\n        }\n    ]\n}", "llm.token_count.prompt": 1211, "llm.token_count.completion": 1072, "llm.token_count.total": 2283, "llm.latency_ms": 8281.607389450073}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:18:38.499466", "span_type": "llm", "prompt_tokens": 1211, "completion_tokens": 1072, "model": "deepseek/deepseek-chat"}
{"span_id": "b2e802d48bbef5ce", "trace_id": "975ead146895f77a44b0e841cada6143", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775120516160600, "end_time": 1755775148682568500, "duration_ns": 28166407900, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 2 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-018.md\\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\\n**GAMP Category**: Ambiguous\\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\\n**Domain**: Analytical Chemistry (QC Lab)\\n**Complexity Level**: Medium\\n\\n## 1. Introduction\\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor\\'s built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier\\'s configuration tools for lab-specific routing.\\n\\n## 2. Functional Requirements\\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\\n- URS-018-003: The module shall provide vendor\\'s standard reporting engine with configured templates for batch results.\\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\\n\\n## 3. Regulatory Requirements\\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\\n- URS-018-015: Report templates shall be controlled artifacts under document control.\\n- URS-018-016: Access controls shall follow least privilege with periodic review.\\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\\n\\n## 4. Performance Requirements\\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\\n\\n## 5. Integration Requirements\\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\\n- URS-018-025: Pull instrument availability and calibration status from asset system.\\n- URS-018-026: Push finalized batch reports to the controlled document repository.\\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002\\n\\nTest IDs: OQ-003 through OQ-004 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-003 through OQ-004\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-003, OQ-004, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-003\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 2 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-018.md\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\n**GAMP Category**: Ambiguous\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\n**Domain**: Analytical Chemistry (QC Lab)\n**Complexity Level**: Medium\n\n## 1. Introduction\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor's built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier's configuration tools for lab-specific routing.\n\n## 2. Functional Requirements\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\n- URS-018-003: The module shall provide vendor's standard reporting engine with configured templates for batch results.\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\n\n## 3. Regulatory Requirements\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\n- URS-018-015: Report templates shall be controlled artifacts under document control.\n- URS-018-016: Access controls shall follow least privilege with periodic review.\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\n\n## 4. Performance Requirements\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\n\n## 5. Integration Requirements\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\n- URS-018-025: Pull instrument availability and calibration status from asset system.\n- URS-018-026: Push finalized batch reports to the controlled document repository.\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002\n\nTest IDs: OQ-003 through OQ-004 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-003 through OQ-004\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-003, OQ-004, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-003\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-003\",\n            \"test_name\": \"Verify Method-Version Locking for Scheduled Runs\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To ensure that the system enforces method-version locking for scheduled runs as per URS-018-002.\",\n            \"prerequisites\": [\"System is installed and operational\", \"Sample run schedules are configured\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Create a sample run schedule with a specific method version.\",\n                    \"expected_result\": \"Schedule is created successfully with the selected method version.\",\n                    \"data_to_capture\": [\"Method version selected\", \"Schedule creation status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Attempt to modify the method version for the scheduled run.\",\n                    \"expected_result\": \"System prevents modification of the method version and displays an error message.\",\n                    \"data_to_capture\": [\"Error message displayed\", \"Method version status\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Method-version locking is enforced for scheduled runs\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Method version integrity must be maintained\"],\n            \"urs_requirements\": [\"URS-018-002\"],\n            \"related_tests\": [\"OQ-001\", \"OQ-002\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Chromatography system knowledge\", \"Scheduling module expertise\"]\n        },\n        {\n            \"test_id\": \"OQ-004\",\n            \"test_name\": \"Validate Gantt View Refresh Performance\",\n            \"test_category\": \"performance\",\n            \"gamp_category\": 4,\n            \"objective\": \"To verify that the Gantt view refresh completes within the specified time limit as per URS-018-023.\",\n            \"prerequisites\": [\"System is installed and operational\", \"Sample run schedules are configured\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Load the Gantt view with a schedule containing 500 samples.\",\n                    \"expected_result\": \"Gantt view is displayed with all 500 samples.\",\n                    \"data_to_capture\": [\"Time taken to load Gantt view\", \"Number of samples displayed\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Refresh the Gantt view and measure the time taken.\",\n                    \"expected_result\": \"Gantt view refresh completes in less than 2 seconds.\",\n                    \"data_to_capture\": [\"Time taken to refresh Gantt view\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Gantt view refresh completes within 2 seconds\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"low\",\n            \"data_integrity_requirements\": [\"Gantt view data must be accurate and up-to-date\"],\n            \"urs_requirements\": [\"URS-018-023\"],\n            \"related_tests\": [\"OQ-001\", \"OQ-002\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Performance testing knowledge\", \"Scheduling module expertise\"]\n        }\n    ]\n}", "llm.token_count.prompt": 1235, "llm.token_count.completion": 866, "llm.token_count.total": 2101, "llm.latency_ms": 28165.90189933777}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:19:08.682719", "span_type": "llm", "prompt_tokens": 1235, "completion_tokens": 866, "model": "deepseek/deepseek-chat"}
{"span_id": "ba21eb2f1c7d4c5c", "trace_id": "2a8f2355e07b6c6986aadba4dfd029a2", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775150690049900, "end_time": 1755775163952272900, "duration_ns": 13262223000, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 3 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-018.md\\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\\n**GAMP Category**: Ambiguous\\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\\n**Domain**: Analytical Chemistry (QC Lab)\\n**Complexity Level**: Medium\\n\\n## 1. Introduction\\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor\\'s built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier\\'s configuration tools for lab-specific routing.\\n\\n## 2. Functional Requirements\\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\\n- URS-018-003: The module shall provide vendor\\'s standard reporting engine with configured templates for batch results.\\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\\n\\n## 3. Regulatory Requirements\\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\\n- URS-018-015: Report templates shall be controlled artifacts under document control.\\n- URS-018-016: Access controls shall follow least privilege with periodic review.\\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\\n\\n## 4. Performance Requirements\\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\\n\\n## 5. Integration Requirements\\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\\n- URS-018-025: Pull instrument availability and calibration status from asset system.\\n- URS-018-026: Push finalized batch reports to the controlled document repository.\\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004\\n\\nTest IDs: OQ-005 through OQ-006 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-005 through OQ-006\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-005, OQ-006, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-005\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 3 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-018.md\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\n**GAMP Category**: Ambiguous\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\n**Domain**: Analytical Chemistry (QC Lab)\n**Complexity Level**: Medium\n\n## 1. Introduction\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor's built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier's configuration tools for lab-specific routing.\n\n## 2. Functional Requirements\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\n- URS-018-003: The module shall provide vendor's standard reporting engine with configured templates for batch results.\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\n\n## 3. Regulatory Requirements\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\n- URS-018-015: Report templates shall be controlled artifacts under document control.\n- URS-018-016: Access controls shall follow least privilege with periodic review.\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\n\n## 4. Performance Requirements\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\n\n## 5. Integration Requirements\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\n- URS-018-025: Pull instrument availability and calibration status from asset system.\n- URS-018-026: Push finalized batch reports to the controlled document repository.\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004\n\nTest IDs: OQ-005 through OQ-006 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-005 through OQ-006\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-005, OQ-006, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-005\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-005\",\n            \"test_name\": \"Verify Sample Run Schedule Creation with Priority and Method Selection\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To verify that users can create sample run schedules with priority, instrument, and method selections as per URS-018-001.\",\n            \"prerequisites\": [\"Access to the chromatography sample scheduling module\", \"Valid user credentials with schedule creation permissions\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the chromatography sample scheduling module.\",\n                    \"expected_result\": \"User successfully logs in and accesses the scheduling interface.\",\n                    \"data_to_capture\": [\"Login status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new sample run schedule with priority, instrument, and method selections.\",\n                    \"expected_result\": \"Schedule is successfully created with the specified priority, instrument, and method.\",\n                    \"data_to_capture\": [\"Schedule details\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Schedule is created with correct priority, instrument, and method selections\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Ensure schedule details are accurately captured and stored\"],\n            \"urs_requirements\": [\"URS-018-001\"],\n            \"related_tests\": [\"OQ-001\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Chromatography scheduling\"]\n        },\n        {\n            \"test_id\": \"OQ-006\",\n            \"test_name\": \"Validate Method-Version Locking Enforcement for Scheduled Runs\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To validate that the system enforces method-version locking for scheduled runs as per URS-018-002.\",\n            \"prerequisites\": [\"Access to the chromatography sample scheduling module\", \"Existing sample run schedule\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the chromatography sample scheduling module.\",\n                    \"expected_result\": \"User successfully logs in and accesses the scheduling interface.\",\n                    \"data_to_capture\": [\"Login status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Attempt to modify the method version of an existing scheduled run.\",\n                    \"expected_result\": \"System prevents modification and enforces method-version locking.\",\n                    \"data_to_capture\": [\"Modification attempt status\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Method-version locking is enforced for scheduled runs\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Ensure method-version locking is accurately enforced\"],\n            \"urs_requirements\": [\"URS-018-002\"],\n            \"related_tests\": [\"OQ-002\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Chromatography scheduling\"]\n        }\n    ]\n}", "llm.token_count.prompt": 1239, "llm.token_count.completion": 871, "llm.token_count.total": 2110, "llm.latency_ms": 13261.985540390015}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:19:23.952389", "span_type": "llm", "prompt_tokens": 1239, "completion_tokens": 871, "model": "deepseek/deepseek-chat"}
{"span_id": "5f2b4cacaafacf36", "trace_id": "77849235e3fbff2eb1063f4400c48c9e", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775165963792800, "end_time": 1755775199226529700, "duration_ns": 33262736900, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 4 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-018.md\\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\\n**GAMP Category**: Ambiguous\\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\\n**Domain**: Analytical Chemistry (QC Lab)\\n**Complexity Level**: Medium\\n\\n## 1. Introduction\\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor\\'s built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier\\'s configuration tools for lab-specific routing.\\n\\n## 2. Functional Requirements\\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\\n- URS-018-003: The module shall provide vendor\\'s standard reporting engine with configured templates for batch results.\\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\\n\\n## 3. Regulatory Requirements\\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\\n- URS-018-015: Report templates shall be controlled artifacts under document control.\\n- URS-018-016: Access controls shall follow least privilege with periodic review.\\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\\n\\n## 4. Performance Requirements\\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\\n\\n## 5. Integration Requirements\\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\\n- URS-018-025: Pull instrument availability and calibration status from asset system.\\n- URS-018-026: Push finalized batch reports to the controlled document repository.\\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006\\n\\nTest IDs: OQ-007 through OQ-008 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-007 through OQ-008\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-007, OQ-008, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-007\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 4 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-018.md\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\n**GAMP Category**: Ambiguous\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\n**Domain**: Analytical Chemistry (QC Lab)\n**Complexity Level**: Medium\n\n## 1. Introduction\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor's built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier's configuration tools for lab-specific routing.\n\n## 2. Functional Requirements\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\n- URS-018-003: The module shall provide vendor's standard reporting engine with configured templates for batch results.\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\n\n## 3. Regulatory Requirements\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\n- URS-018-015: Report templates shall be controlled artifacts under document control.\n- URS-018-016: Access controls shall follow least privilege with periodic review.\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\n\n## 4. Performance Requirements\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\n\n## 5. Integration Requirements\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\n- URS-018-025: Pull instrument availability and calibration status from asset system.\n- URS-018-026: Push finalized batch reports to the controlled document repository.\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006\n\nTest IDs: OQ-007 through OQ-008 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-007 through OQ-008\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-007, OQ-008, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-007\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "```json\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-007\",\n            \"test_name\": \"Method Version Locking Verification\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that the system enforces method-version locking for scheduled runs as per URS-018-002.\",\n            \"prerequisites\": [\n                \"System is installed and configured\",\n                \"User with scheduling permissions is logged in\",\n                \"At least one instrument and method are available\"\n            ],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Create a new sample run schedule and select a method version.\",\n                    \"expected_result\": \"Method version is successfully selected and locked for the schedule.\",\n                    \"data_to_capture\": [\"Method version selected\", \"Lock status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Attempt to modify the method version after scheduling.\",\n                    \"expected_result\": \"System prevents modification of the locked method version.\",\n                    \"data_to_capture\": [\"Error message displayed\", \"Audit trail entry\"]\n                }\n            ],\n            \"acceptance_criteria\": [\n                \"Method version is locked upon scheduling\",\n                \"Modification of locked method version is prevented\",\n                \"Audit trail entry is generated for the lock action\"\n            ],\n            \"regulatory_basis\": [\n                \"21 CFR Part 11\",\n                \"ALCOA+ principles\"\n            ],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\n                \"Method version integrity must be maintained\",\n                \"Audit trail must capture all changes\"\n            ],\n            \"urs_requirements\": [\n                \"URS-018-002\"\n            ],\n            \"related_tests\": [\n                \"OQ-001\",\n                \"OQ-003\"\n            ],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\n                \"Chromatography scheduling\",\n                \"Regulatory compliance\"\n            ]\n        },\n        {\n            \"test_id\": \"OQ-008\",\n            \"test_name\": \"Schedule Gantt View Performance\",\n            \"test_category\": \"performance\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that the Gantt view refreshes within the required time frame as per URS-018-023.\",\n            \"prerequisites\": [\n                \"System is installed and configured\",\n                \"User with scheduling permissions is logged in\",\n                \"At least 100 sample runs are scheduled\"\n            ],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Navigate to the Gantt view and apply a filter by instrument.\",\n                    \"expected_result\": \"Gantt view displays filtered schedule within 2 seconds.\",\n                    \"data_to_capture\": [\"Load time\", \"Filter applied\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Apply a second filter by analyst and observe refresh time.\",\n                    \"expected_result\": \"Gantt view updates with new filter within 2 seconds.\",\n                    \"data_to_capture\": [\"Refresh time\", \"Filter applied\"]\n                }\n            ],\n            \"acceptance_criteria\": [\n                \"Gantt view refreshes within 2 seconds for all filters\",\n                \"Filtered data is accurately displayed\"\n            ],\n            \"regulatory_basis\": [\n                \"URS-018-023\"\n            ],\n            \"risk_level\": \"low\",\n            \"data_integrity_requirements\": [\n                \"Data displayed must be accurate and current\"\n            ],\n            \"urs_requirements\": [\n                \"URS-018-023\"\n            ],\n            \"related_tests\": [\n                \"OQ-006\"\n            ],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\n                \"Performance testing\",\n                \"Chromatography scheduling\"\n            ]\n        }\n    ]\n}\n```", "llm.token_count.prompt": 1243, "llm.token_count.completion": 1068, "llm.token_count.total": 2311, "llm.latency_ms": 33262.356996536255}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:19:59.226705", "span_type": "llm", "prompt_tokens": 1243, "completion_tokens": 1068, "model": "deepseek/deepseek-chat"}
{"span_id": "08648183a10b1779", "trace_id": "b201e8d2f60da26e867eaf79aaa49e51", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775201237922900, "end_time": 1755775212590133300, "duration_ns": 11352210400, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 5 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-018.md\\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\\n**GAMP Category**: Ambiguous\\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\\n**Domain**: Analytical Chemistry (QC Lab)\\n**Complexity Level**: Medium\\n\\n## 1. Introduction\\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor\\'s built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier\\'s configuration tools for lab-specific routing.\\n\\n## 2. Functional Requirements\\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\\n- URS-018-003: The module shall provide vendor\\'s standard reporting engine with configured templates for batch results.\\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\\n\\n## 3. Regulatory Requirements\\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\\n- URS-018-015: Report templates shall be controlled artifacts under document control.\\n- URS-018-016: Access controls shall follow least privilege with periodic review.\\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\\n\\n## 4. Performance Requirements\\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\\n\\n## 5. Integration Requirements\\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\\n- URS-018-025: Pull instrument availability and calibration status from asset system.\\n- URS-018-026: Push finalized batch reports to the controlled document repository.\\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008\\n\\nTest IDs: OQ-009 through OQ-010 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-009 through OQ-010\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-009, OQ-010, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-009\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 5 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-018.md\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\n**GAMP Category**: Ambiguous\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\n**Domain**: Analytical Chemistry (QC Lab)\n**Complexity Level**: Medium\n\n## 1. Introduction\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor's built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier's configuration tools for lab-specific routing.\n\n## 2. Functional Requirements\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\n- URS-018-003: The module shall provide vendor's standard reporting engine with configured templates for batch results.\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\n\n## 3. Regulatory Requirements\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\n- URS-018-015: Report templates shall be controlled artifacts under document control.\n- URS-018-016: Access controls shall follow least privilege with periodic review.\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\n\n## 4. Performance Requirements\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\n\n## 5. Integration Requirements\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\n- URS-018-025: Pull instrument availability and calibration status from asset system.\n- URS-018-026: Push finalized batch reports to the controlled document repository.\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008\n\nTest IDs: OQ-009 through OQ-010 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-009 through OQ-010\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-009, OQ-010, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-009\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-009\",\n            \"test_name\": \"Schedule Creation and Method Version Locking\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that users can create sample run schedules with priority, instrument, and method selections, and that the system enforces method-version locking for scheduled runs.\",\n            \"prerequisites\": [\"Access to the Chromatography Sample Scheduling Module\", \"Configured instruments and methods\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system with appropriate user credentials.\",\n                    \"expected_result\": \"User successfully logs in and gains access to the scheduling module.\",\n                    \"data_to_capture\": [\"User credentials\", \"Login status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new sample run schedule with priority, instrument, and method selections.\",\n                    \"expected_result\": \"Schedule is successfully created with specified parameters.\",\n                    \"data_to_capture\": [\"Schedule details\", \"Priority\", \"Instrument\", \"Method\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Attempt to modify the method version for the scheduled run.\",\n                    \"expected_result\": \"System prevents modification and enforces method-version locking.\",\n                    \"data_to_capture\": [\"Method version\", \"Modification attempt status\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Schedule creation is successful\", \"Method-version locking is enforced\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\", \"ALCOA+\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Audit trail entries for schedule changes\"],\n            \"urs_requirements\": [\"URS-018-001\", \"URS-018-002\"],\n            \"related_tests\": [\"OQ-001\", \"OQ-002\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Chromatography scheduling\", \"Method version control\"]\n        },\n        {\n            \"test_id\": \"OQ-010\",\n            \"test_name\": \"Instrument Readiness Alerts and Run Completion Notifications\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Ensure that users receive alerts for instrument readiness and run completion as specified in the requirements.\",\n            \"prerequisites\": [\"Access to the Chromatography Sample Scheduling Module\", \"Configured instruments and methods\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system with appropriate user credentials.\",\n                    \"expected_result\": \"User successfully logs in and gains access to the scheduling module.\",\n                    \"data_to_capture\": [\"User credentials\", \"Login status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Schedule a sample run and wait for instrument readiness.\",\n                    \"expected_result\": \"User receives an alert indicating instrument readiness.\",\n                    \"data_to_capture\": [\"Alert details\", \"Instrument readiness status\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Complete the scheduled run and wait for run completion notification.\",\n                    \"expected_result\": \"User receives a notification indicating run completion.\",\n                    \"data_to_capture\": [\"Notification details\", \"Run completion status\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Alerts for instrument readiness are received\", \"Notifications for run completion are received\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\", \"ALCOA+\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Audit trail entries for alerts and notifications\"],\n            \"urs_requirements\": [\"URS-018-007\"],\n            \"related_tests\": [\"OQ-003\", \"OQ-004\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Chromatography scheduling\", \"Alert and notification systems\"]\n        }\n    ]\n}", "llm.token_count.prompt": 1247, "llm.token_count.completion": 1103, "llm.token_count.total": 2350, "llm.latency_ms": 11351.938009262085}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:20:12.590256", "span_type": "llm", "prompt_tokens": 1247, "completion_tokens": 1103, "model": "deepseek/deepseek-chat"}
{"span_id": "adb58b2e72da02b6", "trace_id": "7ce7bb15334596d978f790502803ac2a", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775214603526800, "end_time": 1755775250031415500, "duration_ns": 35427888700, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 6 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-018.md\\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\\n**GAMP Category**: Ambiguous\\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\\n**Domain**: Analytical Chemistry (QC Lab)\\n**Complexity Level**: Medium\\n\\n## 1. Introduction\\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor\\'s built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier\\'s configuration tools for lab-specific routing.\\n\\n## 2. Functional Requirements\\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\\n- URS-018-003: The module shall provide vendor\\'s standard reporting engine with configured templates for batch results.\\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\\n\\n## 3. Regulatory Requirements\\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\\n- URS-018-015: Report templates shall be controlled artifacts under document control.\\n- URS-018-016: Access controls shall follow least privilege with periodic review.\\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\\n\\n## 4. Performance Requirements\\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\\n\\n## 5. Integration Requirements\\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\\n- URS-018-025: Pull instrument availability and calibration status from asset system.\\n- URS-018-026: Push finalized batch reports to the controlled document repository.\\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010\\n\\nTest IDs: OQ-011 through OQ-012 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-011 through OQ-012\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-011, OQ-012, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-011\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 6 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-018.md\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\n**GAMP Category**: Ambiguous\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\n**Domain**: Analytical Chemistry (QC Lab)\n**Complexity Level**: Medium\n\n## 1. Introduction\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor's built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier's configuration tools for lab-specific routing.\n\n## 2. Functional Requirements\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\n- URS-018-003: The module shall provide vendor's standard reporting engine with configured templates for batch results.\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\n\n## 3. Regulatory Requirements\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\n- URS-018-015: Report templates shall be controlled artifacts under document control.\n- URS-018-016: Access controls shall follow least privilege with periodic review.\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\n\n## 4. Performance Requirements\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\n\n## 5. Integration Requirements\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\n- URS-018-025: Pull instrument availability and calibration status from asset system.\n- URS-018-026: Push finalized batch reports to the controlled document repository.\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010\n\nTest IDs: OQ-011 through OQ-012 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-011 through OQ-012\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-011, OQ-012, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-011\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-011\",\n            \"test_name\": \"Verify Schedule Creation with Priority and Method Locking\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To verify that users can create sample run schedules with priority, instrument, and method selections, and that method-version locking is enforced.\",\n            \"prerequisites\": [\"System is installed and configured\", \"User roles and permissions are set up\", \"Instrument and method data are available\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system with a user account that has schedule creation permissions.\",\n                    \"expected_result\": \"User is successfully logged in and can access the scheduling module.\",\n                    \"data_to_capture\": [\"User login status\", \"Access to scheduling module\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new sample run schedule with priority, instrument, and method selections.\",\n                    \"expected_result\": \"Schedule is created successfully with the specified priority, instrument, and method.\",\n                    \"data_to_capture\": [\"Schedule details\", \"Priority, instrument, and method selections\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Attempt to modify the method version for the scheduled run.\",\n                    \"expected_result\": \"System enforces method-version locking and prevents modification.\",\n                    \"data_to_capture\": [\"Method version locking status\", \"Error message if modification is attempted\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Schedule is created with correct priority, instrument, and method\", \"Method-version locking is enforced\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\", \"ALCOA+\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Audit trail entries are generated for all changes to schedule entries\"],\n            \"urs_requirements\": [\"URS-018-001\", \"URS-018-002\", \"URS-018-006\"],\n            \"related_tests\": [\"OQ-001\", \"OQ-002\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"System configuration\", \"User role management\", \"Method version control\"]\n        },\n        {\n            \"test_id\": \"OQ-012\",\n            \"test_name\": \"Validate Integration with Asset System for Instrument Availability\",\n            \"test_category\": \"integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"To validate that the system can pull instrument availability and calibration status from the asset system.\",\n            \"prerequisites\": [\"System is installed and configured\", \"Asset system is available and configured\", \"Instrument data is available in the asset system\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system with a user account that has integration permissions.\",\n                    \"expected_result\": \"User is successfully logged in and can access the integration module.\",\n                    \"data_to_capture\": [\"User login status\", \"Access to integration module\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Initiate a request to pull instrument availability and calibration status from the asset system.\",\n                    \"expected_result\": \"System successfully retrieves instrument availability and calibration status.\",\n                    \"data_to_capture\": [\"Instrument availability status\", \"Calibration status\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Verify that the retrieved data is correctly displayed in the system.\",\n                    \"expected_result\": \"Instrument availability and calibration status are correctly displayed in the system.\",\n                    \"data_to_capture\": [\"Displayed instrument availability\", \"Displayed calibration status\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Instrument availability and calibration status are successfully retrieved\", \"Retrieved data is correctly displayed in the system\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\", \"ALCOA+\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Audit trail entries are generated for all integration actions\"],\n            \"urs_requirements\": [\"URS-018-025\"],\n            \"related_tests\": [\"OQ-003\", \"OQ-004\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"System integration\", \"Asset system configuration\", \"Data validation\"]\n        }\n    ]\n}", "llm.token_count.prompt": 1251, "llm.token_count.completion": 1223, "llm.token_count.total": 2474, "llm.latency_ms": 35427.64902114868}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:20:50.031550", "span_type": "llm", "prompt_tokens": 1251, "completion_tokens": 1223, "model": "deepseek/deepseek-chat"}
{"span_id": "dbd0a4d89a062fcd", "trace_id": "ea30e5f2a2f908c4863d170dfccee0d0", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775252037024200, "end_time": 1755775262837435200, "duration_ns": 10800411000, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 7 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-018.md\\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\\n**GAMP Category**: Ambiguous\\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\\n**Domain**: Analytical Chemistry (QC Lab)\\n**Complexity Level**: Medium\\n\\n## 1. Introduction\\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor\\'s built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier\\'s configuration tools for lab-specific routing.\\n\\n## 2. Functional Requirements\\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\\n- URS-018-003: The module shall provide vendor\\'s standard reporting engine with configured templates for batch results.\\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\\n\\n## 3. Regulatory Requirements\\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\\n- URS-018-015: Report templates shall be controlled artifacts under document control.\\n- URS-018-016: Access controls shall follow least privilege with periodic review.\\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\\n\\n## 4. Performance Requirements\\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\\n\\n## 5. Integration Requirements\\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\\n- URS-018-025: Pull instrument availability and calibration status from asset system.\\n- URS-018-026: Push finalized batch reports to the controlled document repository.\\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012\\n\\nTest IDs: OQ-013 through OQ-014 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-013 through OQ-014\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-013, OQ-014, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-013\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 7 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-018.md\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\n**GAMP Category**: Ambiguous\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\n**Domain**: Analytical Chemistry (QC Lab)\n**Complexity Level**: Medium\n\n## 1. Introduction\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor's built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier's configuration tools for lab-specific routing.\n\n## 2. Functional Requirements\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\n- URS-018-003: The module shall provide vendor's standard reporting engine with configured templates for batch results.\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\n\n## 3. Regulatory Requirements\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\n- URS-018-015: Report templates shall be controlled artifacts under document control.\n- URS-018-016: Access controls shall follow least privilege with periodic review.\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\n\n## 4. Performance Requirements\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\n\n## 5. Integration Requirements\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\n- URS-018-025: Pull instrument availability and calibration status from asset system.\n- URS-018-026: Push finalized batch reports to the controlled document repository.\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012\n\nTest IDs: OQ-013 through OQ-014 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-013 through OQ-014\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-013, OQ-014, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-013\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-013\",\n            \"test_name\": \"Verify Schedule Creation with Priority and Method Locking\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Ensure that users can create sample run schedules with priority, instrument, and method selections, and that method-version locking is enforced.\",\n            \"prerequisites\": [\"Access to the scheduling module\", \"Configured instruments and methods\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system with appropriate credentials.\",\n                    \"expected_result\": \"User successfully logs in and accesses the scheduling module.\",\n                    \"data_to_capture\": [\"Login status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new sample run schedule with priority, instrument, and method selections.\",\n                    \"expected_result\": \"Schedule is created with the specified priority, instrument, and method.\",\n                    \"data_to_capture\": [\"Schedule details\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Attempt to modify the method version for the scheduled run.\",\n                    \"expected_result\": \"System prevents modification and enforces method-version locking.\",\n                    \"data_to_capture\": [\"Method version status\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Schedule is created successfully\", \"Method-version locking is enforced\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Ensure all schedule changes are logged in the audit trail\"],\n            \"urs_requirements\": [\"URS-018-001\", \"URS-018-002\"],\n            \"related_tests\": [\"OQ-014\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Chromatography scheduling\"]\n        },\n        {\n            \"test_id\": \"OQ-014\",\n            \"test_name\": \"Validate Instrument Readiness Alerts and Run Completion Notifications\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that users receive alerts for instrument readiness and run completion within the specified time frame.\",\n            \"prerequisites\": [\"Access to the scheduling module\", \"Configured instruments\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system with appropriate credentials.\",\n                    \"expected_result\": \"User successfully logs in and accesses the scheduling module.\",\n                    \"data_to_capture\": [\"Login status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Schedule a sample run and monitor for instrument readiness alert.\",\n                    \"expected_result\": \"Alert is received within 5 seconds of instrument readiness.\",\n                    \"data_to_capture\": [\"Alert timing\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Complete the sample run and monitor for run completion notification.\",\n                    \"expected_result\": \"Notification is received within 5 seconds of run completion.\",\n                    \"data_to_capture\": [\"Notification timing\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Alerts and notifications are received within 5 seconds\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Ensure all alerts and notifications are logged in the audit trail\"],\n            \"urs_requirements\": [\"URS-018-007\"],\n            \"related_tests\": [\"OQ-013\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Chromatography scheduling\"]\n        }\n    ]\n}", "llm.token_count.prompt": 1255, "llm.token_count.completion": 1024, "llm.token_count.total": 2279, "llm.latency_ms": 10800.101280212402}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:21:02.837578", "span_type": "llm", "prompt_tokens": 1255, "completion_tokens": 1024, "model": "deepseek/deepseek-chat"}
{"span_id": "bc5f24af336df7fb", "trace_id": "ddb075a0a241fe2208dd157c59b67a66", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775264845062400, "end_time": 1755775287799590300, "duration_ns": 22954527900, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 8 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-018.md\\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\\n**GAMP Category**: Ambiguous\\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\\n**Domain**: Analytical Chemistry (QC Lab)\\n**Complexity Level**: Medium\\n\\n## 1. Introduction\\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor\\'s built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier\\'s configuration tools for lab-specific routing.\\n\\n## 2. Functional Requirements\\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\\n- URS-018-003: The module shall provide vendor\\'s standard reporting engine with configured templates for batch results.\\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\\n\\n## 3. Regulatory Requirements\\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\\n- URS-018-015: Report templates shall be controlled artifacts under document control.\\n- URS-018-016: Access controls shall follow least privilege with periodic review.\\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\\n\\n## 4. Performance Requirements\\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\\n\\n## 5. Integration Requirements\\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\\n- URS-018-025: Pull instrument availability and calibration status from asset system.\\n- URS-018-026: Push finalized batch reports to the controlled document repository.\\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012, OQ-013, OQ-014\\n\\nTest IDs: OQ-015 through OQ-016 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-015 through OQ-016\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-015, OQ-016, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-015\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 8 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-018.md\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\n**GAMP Category**: Ambiguous\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\n**Domain**: Analytical Chemistry (QC Lab)\n**Complexity Level**: Medium\n\n## 1. Introduction\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor's built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier's configuration tools for lab-specific routing.\n\n## 2. Functional Requirements\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\n- URS-018-003: The module shall provide vendor's standard reporting engine with configured templates for batch results.\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\n\n## 3. Regulatory Requirements\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\n- URS-018-015: Report templates shall be controlled artifacts under document control.\n- URS-018-016: Access controls shall follow least privilege with periodic review.\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\n\n## 4. Performance Requirements\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\n\n## 5. Integration Requirements\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\n- URS-018-025: Pull instrument availability and calibration status from asset system.\n- URS-018-026: Push finalized batch reports to the controlled document repository.\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012, OQ-013, OQ-014\n\nTest IDs: OQ-015 through OQ-016 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-015 through OQ-016\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-015, OQ-016, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-015\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-015\",\n            \"test_name\": \"Verify Schedule Gantt View Performance\",\n            \"test_category\": \"performance\",\n            \"gamp_category\": 4,\n            \"objective\": \"Ensure the Gantt view refreshes within the specified time limit under typical load conditions.\",\n            \"prerequisites\": [\"System is operational\", \"Sample schedules are loaded\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Load a schedule with 500 samples into the system.\",\n                    \"expected_result\": \"Schedule is loaded successfully without errors.\",\n                    \"data_to_capture\": [\"Load time\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Open the Gantt view and filter by instrument and analyst.\",\n                    \"expected_result\": \"Gantt view displays the filtered schedule correctly.\",\n                    \"data_to_capture\": [\"Refresh time\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Gantt view refresh completes in < 2 seconds\"],\n            \"regulatory_basis\": [\"URS-018-023\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Ensure data displayed in Gantt view is accurate and consistent\"],\n            \"urs_requirements\": [\"URS-018-012\", \"URS-018-023\"],\n            \"related_tests\": [\"OQ-001\", \"OQ-002\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Performance testing\", \"System configuration\"]\n        },\n        {\n            \"test_id\": \"OQ-016\",\n            \"test_name\": \"Validate Integration with Asset System\",\n            \"test_category\": \"integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"Confirm the system correctly pulls instrument availability and calibration status from the asset system.\",\n            \"prerequisites\": [\"Asset system is operational\", \"Integration is configured\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Configure the system to connect to the asset system.\",\n                    \"expected_result\": \"Connection is established successfully.\",\n                    \"data_to_capture\": [\"Connection status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Request instrument availability and calibration status from the asset system.\",\n                    \"expected_result\": \"Correct instrument status is retrieved and displayed in the system.\",\n                    \"data_to_capture\": [\"Retrieved data\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Instrument availability and calibration status are accurately pulled from the asset system\"],\n            \"regulatory_basis\": [\"URS-018-025\"],\n            \"risk_level\": \"high\",\n            \"data_integrity_requirements\": [\"Ensure data retrieved from the asset system is accurate and consistent\"],\n            \"urs_requirements\": [\"URS-018-025\"],\n            \"related_tests\": [\"OQ-003\", \"OQ-004\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Integration testing\", \"System configuration\"]\n        }\n    ]\n}", "llm.token_count.prompt": 1259, "llm.token_count.completion": 825, "llm.token_count.total": 2084, "llm.latency_ms": 22954.299211502075}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:21:27.799700", "span_type": "llm", "prompt_tokens": 1259, "completion_tokens": 825, "model": "deepseek/deepseek-chat"}
{"span_id": "f44ce99b7347d707", "trace_id": "10d638fad131c0024abd31d44278e2e9", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775289801857200, "end_time": 1755775318746392800, "duration_ns": 28944535600, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 9 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-018.md\\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\\n**GAMP Category**: Ambiguous\\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\\n**Domain**: Analytical Chemistry (QC Lab)\\n**Complexity Level**: Medium\\n\\n## 1. Introduction\\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor\\'s built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier\\'s configuration tools for lab-specific routing.\\n\\n## 2. Functional Requirements\\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\\n- URS-018-003: The module shall provide vendor\\'s standard reporting engine with configured templates for batch results.\\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\\n\\n## 3. Regulatory Requirements\\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\\n- URS-018-015: Report templates shall be controlled artifacts under document control.\\n- URS-018-016: Access controls shall follow least privilege with periodic review.\\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\\n\\n## 4. Performance Requirements\\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\\n\\n## 5. Integration Requirements\\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\\n- URS-018-025: Pull instrument availability and calibration status from asset system.\\n- URS-018-026: Push finalized batch reports to the controlled document repository.\\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012, OQ-013, OQ-014, OQ-015, OQ-016\\n\\nTest IDs: OQ-017 through OQ-018 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-017 through OQ-018\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-017, OQ-018, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-017\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 9 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-018.md\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\n**GAMP Category**: Ambiguous\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\n**Domain**: Analytical Chemistry (QC Lab)\n**Complexity Level**: Medium\n\n## 1. Introduction\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor's built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier's configuration tools for lab-specific routing.\n\n## 2. Functional Requirements\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\n- URS-018-003: The module shall provide vendor's standard reporting engine with configured templates for batch results.\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\n\n## 3. Regulatory Requirements\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\n- URS-018-015: Report templates shall be controlled artifacts under document control.\n- URS-018-016: Access controls shall follow least privilege with periodic review.\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\n\n## 4. Performance Requirements\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\n\n## 5. Integration Requirements\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\n- URS-018-025: Pull instrument availability and calibration status from asset system.\n- URS-018-026: Push finalized batch reports to the controlled document repository.\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012, OQ-013, OQ-014, OQ-015, OQ-016\n\nTest IDs: OQ-017 through OQ-018 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-017 through OQ-018\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-017, OQ-018, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-017\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-017\",\n            \"test_name\": \"Verify Schedule Creation with Method-Version Locking\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To ensure that the system enforces method-version locking when creating sample run schedules.\",\n            \"prerequisites\": [\"System is operational\", \"User has appropriate role-based access\", \"Method versions are configured\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system with a user account that has schedule creation permissions.\",\n                    \"expected_result\": \"User successfully logs in and navigates to the schedule creation interface.\",\n                    \"data_to_capture\": [\"Login status\", \"User role\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Attempt to create a sample run schedule with a locked method version.\",\n                    \"expected_result\": \"System prevents the creation of the schedule and displays an error message indicating method-version locking.\",\n                    \"data_to_capture\": [\"Error message\", \"Method version status\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"System enforces method-version locking as expected\", \"Error message is clear and accurate\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\", \"ALCOA+\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Audit trail entries for schedule creation attempts\"],\n            \"urs_requirements\": [\"URS-018-002\"],\n            \"related_tests\": [\"OQ-001\", \"OQ-002\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"System configuration\", \"Regulatory compliance\"]\n        },\n        {\n            \"test_id\": \"OQ-018\",\n            \"test_name\": \"Validate Gantt View Refresh Performance\",\n            \"test_category\": \"performance\",\n            \"gamp_category\": 4,\n            \"objective\": \"To verify that the Gantt view refreshes within the specified time limit under typical conditions.\",\n            \"prerequisites\": [\"System is operational\", \"Sample schedules are loaded\", \"Gantt view is accessible\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system with a user account that has access to the Gantt view.\",\n                    \"expected_result\": \"User successfully logs in and navigates to the Gantt view interface.\",\n                    \"data_to_capture\": [\"Login status\", \"User role\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Initiate a refresh of the Gantt view and measure the time taken to complete.\",\n                    \"expected_result\": \"Gantt view refreshes in less than 2 seconds.\",\n                    \"data_to_capture\": [\"Refresh time\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Gantt view refresh completes within 2 seconds\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"low\",\n            \"data_integrity_requirements\": [\"Audit trail entries for Gantt view access\"],\n            \"urs_requirements\": [\"URS-018-023\"],\n            \"related_tests\": [\"OQ-003\", \"OQ-004\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Performance testing\", \"System configuration\"]\n        }\n    ]\n}", "llm.token_count.prompt": 1263, "llm.token_count.completion": 885, "llm.token_count.total": 2148, "llm.latency_ms": 28944.28515434265}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:21:58.746511", "span_type": "llm", "prompt_tokens": 1263, "completion_tokens": 885, "model": "deepseek/deepseek-chat"}
{"span_id": "305dacff8a35d283", "trace_id": "57279046fbb37916f9943bb7073867c3", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755775320760976800, "end_time": 1755775333969734200, "duration_ns": 13208757400, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 10 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-018.md\\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\\n**GAMP Category**: Ambiguous\\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\\n**Domain**: Analytical Chemistry (QC Lab)\\n**Complexity Level**: Medium\\n\\n## 1. Introduction\\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor\\'s built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier\\'s configuration tools for lab-specific routing.\\n\\n## 2. Functional Requirements\\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\\n- URS-018-003: The module shall provide vendor\\'s standard reporting engine with configured templates for batch results.\\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\\n\\n## 3. Regulatory Requirements\\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\\n- URS-018-015: Report templates shall be controlled artifacts under document control.\\n- URS-018-016: Access controls shall follow least privilege with periodic review.\\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\\n\\n## 4. Performance Requirements\\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\\n\\n## 5. Integration Requirements\\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\\n- URS-018-025: Pull instrument availability and calibration status from asset system.\\n- URS-018-026: Push finalized batch reports to the controlled document repository.\\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012, OQ-013, OQ-014, OQ-015, OQ-016, OQ-017, OQ-018\\n\\nTest IDs: OQ-019 through OQ-020 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-019 through OQ-020\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-019, OQ-020, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-019\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 10 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-018.md\nURS CONTENT: # URS-018: Chromatography Sample Scheduling Module\n**GAMP Category**: Ambiguous\n**System Type**: Scheduling and reporting add-on for CDS/LIMS\n**Domain**: Analytical Chemistry (QC Lab)\n**Complexity Level**: Medium\n\n## 1. Introduction\nThis module provides laboratory analysts with a standardized way to schedule chromatography sample runs and generate compliance-ready reports. The capability can be realized using the vendor's built-in scheduling and reporting features (commercial off-the-shelf) or by configuring workflow templates and parameters via the supplier's configuration tools for lab-specific routing.\n\n## 2. Functional Requirements\n- URS-018-001: Users shall create sample run schedules with priority, instrument, and method selections.\n- URS-018-002: The system shall enforce method-version locking for scheduled runs.\n- URS-018-003: The module shall provide vendor's standard reporting engine with configured templates for batch results.\n- URS-018-004: Users shall route samples to instruments based on configured availability rules.\n- URS-018-005: The system shall support pause/resume and re-queue of failed runs with reason capture.\n- URS-018-006: Audit trail entries shall be generated for all changes to schedule entries.\n- URS-018-007: Users shall receive alerts for instrument readiness and run completion.\n- URS-018-008: Role-based access shall control schedule creation, approval, and execution.\n- URS-018-009: The system shall support configured hold rules when stability chambers report excursions.\n- URS-018-010: Configurable approvals shall be required prior to execution of GMP runs.\n- URS-018-011: The system shall generate exception summaries for out-of-trend runs.\n- URS-018-012: The system shall provide a schedule Gantt view filtered by instrument and analyst.\n\n## 3. Regulatory Requirements\n- URS-018-013: Electronic records shall comply with 21 CFR Part 11 including electronic signatures.\n- URS-018-014: All actions shall be captured in a secure, time-stamped audit trail (ALCOA+).\n- URS-018-015: Report templates shall be controlled artifacts under document control.\n- URS-018-016: Access controls shall follow least privilege with periodic review.\n- URS-018-017: System shall support retention and retrieval for the required regulatory period.\n\n## 4. Performance Requirements\n- URS-018-018: Load 500-sample schedules in < 3 seconds in typical conditions.\n- URS-018-019: Generate standard batch report within 10 seconds for 200 injections.\n- URS-018-020: Support concurrent access by 30 users with no functional degradation.\n- URS-018-021: System availability shall be \u2265 99.5% during lab operating hours.\n- URS-018-022: Alerts shall be delivered within 5 seconds of event detection.\n- URS-018-023: Gantt view refresh shall complete in < 2 seconds.\n\n## 5. Integration Requirements\n- URS-018-024: Integrate with vendor CDS/LIMS via standard APIs or vendor-approved connectors.\n- URS-018-025: Pull instrument availability and calibration status from asset system.\n- URS-018-026: Push finalized batch reports to the controlled document repository.\n- URS-018-027: Support LDAP/AD for user authentication and role sync.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012, OQ-013, OQ-014, OQ-015, OQ-016, OQ-017, OQ-018\n\nTest IDs: OQ-019 through OQ-020 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-019 through OQ-020\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-019, OQ-020, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-019\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-019\",\n            \"test_name\": \"Verify Schedule Creation with Priority and Method Locking\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To ensure that users can create sample run schedules with priority, instrument, and method selections, and that method-version locking is enforced for scheduled runs.\",\n            \"prerequisites\": [\"Access to the Chromatography Sample Scheduling Module\", \"Configured instruments and methods\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system with appropriate credentials.\",\n                    \"expected_result\": \"User successfully logs in and accesses the scheduling module.\",\n                    \"data_to_capture\": [\"Login status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new sample run schedule with priority, instrument, and method selections.\",\n                    \"expected_result\": \"Schedule is created with the specified priority, instrument, and method.\",\n                    \"data_to_capture\": [\"Schedule details\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Attempt to modify the method version for the scheduled run.\",\n                    \"expected_result\": \"System prevents modification and enforces method-version locking.\",\n                    \"data_to_capture\": [\"Method version status\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Schedule is created successfully\", \"Method-version locking is enforced\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Audit trail entries for schedule changes\"],\n            \"urs_requirements\": [\"URS-018-001\", \"URS-018-002\"],\n            \"related_tests\": [\"OQ-001\", \"OQ-002\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Chromatography\", \"Scheduling\"]\n        },\n        {\n            \"test_id\": \"OQ-020\",\n            \"test_name\": \"Validate Gantt View Refresh Performance\",\n            \"test_category\": \"performance\",\n            \"gamp_category\": 4,\n            \"objective\": \"To verify that the Gantt view refresh completes within the specified time frame of less than 2 seconds.\",\n            \"prerequisites\": [\"Access to the Chromatography Sample Scheduling Module\", \"Existing schedules\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system with appropriate credentials.\",\n                    \"expected_result\": \"User successfully logs in and accesses the scheduling module.\",\n                    \"data_to_capture\": [\"Login status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Navigate to the Gantt view and apply filters by instrument and analyst.\",\n                    \"expected_result\": \"Gantt view displays filtered schedules.\",\n                    \"data_to_capture\": [\"Filtered schedules\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Measure the time taken for the Gantt view to refresh.\",\n                    \"expected_result\": \"Gantt view refresh completes in less than 2 seconds.\",\n                    \"data_to_capture\": [\"Refresh time\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Gantt view refresh completes within 2 seconds\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"low\",\n            \"data_integrity_requirements\": [\"Audit trail entries for view changes\"],\n            \"urs_requirements\": [\"URS-018-023\"],\n            \"related_tests\": [\"OQ-003\", \"OQ-004\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Chromatography\", \"Performance Testing\"]\n        }\n    ]\n}", "llm.token_count.prompt": 1268, "llm.token_count.completion": 1016, "llm.token_count.total": 2284, "llm.latency_ms": 13208.512783050537}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:22:13.969859", "span_type": "llm", "prompt_tokens": 1268, "completion_tokens": 1016, "model": "deepseek/deepseek-chat"}
